plants
The Rapé Ceremony: Tradition, Process and Safety
This article is part of our Rapé Guide. TL;DR The Rapé ceremony is a living ritual practice of numerous indigenous peoples of the western Amazon basin — not a recreational activity, but a sacred act with deep cultural roots. Indigenous origins: Peoples such as the Yawanawá, Huni Kuin, Kuntanawa, Nukini, Apurinã, Katukina, Shanenawa and Matsés each maintain their own distinct ceremonial styles and Rapé formulas. Tools: The Tepi (partner-based application) and the Kuripe (self-application) structure the ceremonial process. Set & Setting: Mental preparation, intention-setting and a calm, safe framework are not optional extras, but constitutive elements of a responsible practice. Safety: Rapé contains highly concentrated nicotine from Nicotiana rustica. The ceremony is contraindicated for cardiovascular conditions, pregnancy, and use of MAOIs or SSRIs. Neoshamanism vs. tradition: The spread of Rapé in Europe calls for a reflective approach to cultural appropriation, facilitator quality and respect for the communities of origin. Indigenous Roots: Who Practises Rapé? Rapé — pronounced "ha-PEH" — is not a new wellness invention. It is a millennia-old ceremonial tool used by numerous indigenous communities in the western Amazon basin, primarily in the Brazilian state of Acre as well as in adjacent regions of Peru and Colombia. The peoples involved are diverse, and their Rapé traditions differ considerably from one another: Yawanawá (Acre, Brazil): The Yawanawá are regarded as one of the best-known guardians of the Rapé tradition. Their ceremonies are closely interwoven with Uni (Ayahuasca) and encompass extended singing rituals (Mariri songs), body painting and multi-day fasts. Rapé serves here for grounding, spiritual cleansing and making contact with ancestors. Huni Kuin / Kaxinawá (Acre/Peru): The Huni Kuin people possess a rich tradition of ceremonial songs (Icaros) and use Rapé as an integral component of healing rituals and as preparation for Nixi Pae (Ayahuasca). Their Rapé formulas frequently include Tsunu ash and selected herbs. Kuntanawa (Acre, Brazil): A smaller people with a particularly intensive tradition of herbal knowledge. Kuntanawa Rapé is considered comparatively mild and is also employed during community conversations and decision-making processes. Nukini (Acre, Brazil): The Nukini combine Rapé ceremonies with Pajé practices (shamanic work) and use it specifically in diagnostic sessions. Apurinã (Amazonas, Brazil): In the Apurinã tradition, Rapé has a pronounced social function: sharing the snuff tobacco with elders is a sign of respect and connection. Katukina (Acre/Amazonas, Brazil): The Katukina are known as the original guardians of Kambo, yet Rapé also plays an essential role in their ceremonies — often in combination with other plant medicines. Shanenawa (Acre, Brazil): Shanenawa ceremonies are known for their connection with song and healing plants. Rapé is used here for Limpieza — spiritual cleansing. Matsés / Mayoruna (Peru/Brazil): The Matsés, also known as the "Cat People," use Rapé particularly in preparation for hunting: for sharpening the senses, focusing the mind and communicating with the forest spirit. In all of these traditions, Rapé is not an isolated product but is embedded within a comprehensive cosmological and healing understanding. It is traditionally: used as preparation or grounding before and after Ayahuasca ceremonies, employed in Limpiezas (spiritual cleansing rituals), used to concentrate and sharpen the senses before hunting, incorporated in community rituals such as births and rites of passage, and shared during consultations with elders and leaders. Rapé in the Western World: From the 1990s onwards, Brazilian neoshamanic centres — including those associated with religious organisations such as Santo Daime and União do Vegetal — began introducing Rapé into broader spiritual contexts. In European Ayahuasca communities it found wider acceptance from the turn of the millennium; since the 2010s there have also been standalone Rapé ceremonies in Europe, detached from the Ayahuasca context. This development is not without tension: questions of cultural appropriation, facilitator qualification and respect towards the communities of origin arise here with full weight. From the archive Nicotiana rustica — Aztec tobacco (mapacho) Nicotiana rustica in flower — the Amazonian "mapacho" tobacco used as the base for traditional rapé. Wikimedia Commons · CC BY-SA Set and Setting The concept of "set" (inner disposition) and "setting" (outer framework) — familiar from psychedelic research — is equally relevant to the Rapé ceremony, even though Rapé is not considered a psychedelic. Pyridine alkaloid · Nicotiana rustica & N. tabacum nicotine 3-[(2S)-1-methylpyrrolidin-2-yl]pyridine Molecular formula: C10H14N2 Molecular weight: 162.23 g/mol CAS: 54-11-5 Compound profile: nicotine → Setting: Ideally, a Rapé ceremony takes place in a quiet, tidy space — whether outdoors in nature or in a shielded interior room. Disturbances should be avoided. Cushions, an upright and dignified posture, and the provision of fresh water and, if necessary, a bowl are part of the basic equipment. Many practitioners light Palo Santo or incense for space clearing. Set: Mental preparation is equally important. The central question is: Why am I taking Rapé today? Formulating a concrete intention — whether clarity, grounding, letting go or a prayer — gives the experience direction and depth. On the day of the ceremony, experienced facilitators typically recommend: abstaining from alcohol, light or no meals in the hours beforehand, avoiding intense digital stimuli, a quiet preparation through meditation, movement or writing down notes on one's own intention. The Sequence of a Typical Rapé Ceremony The following sequence describes a frequently practised form of the ceremony as it is encountered in European contexts with neoshamanic influences. It makes no claim to universal validity — the diversity of indigenous traditions cannot be reduced to a single template. 1. Preparation of the Space The facilitator prepares the space: incense (Palo Santo, Copal or frankincense), water, a bowl, sitting cushions. Sometimes plants, feathers or other sacred objects are arranged. The space is kept in silence. 2. Setting of Intention Participants and facilitator take time together for a brief silence or an opening prayer. Each participant is invited to formulate — inwardly or aloud — a question or intention. This anchors the experience. 3. Tepi Application (Two Persons, Traditional) The recipient sits upright, spine straight, both feet on the ground. The facilitator fills the Tepi — a long, curved pipe — with a small portion of Rapé. Traditionally the application begins in the left nostril, which in some traditions is associated with the receptive, "feminine" side; the right then follows. The recipient exhales fully and holds the breath briefly. The facilitator blows in one powerful, steady breath — not in short bursts, but as a conscious gesture of transmission. The Tepi should rest gently but securely against the nostril. 4. Integration (5–20 Minutes) After the application, an immediate and intense sensation occurs: pressure in the nose and head, a strong tingling, tearing of the eyes, and sometimes coughing or clearing of the throat. These reactions are regarded in the tradition as cleansing — physiologically they reflect the mucosal irritation and rapid nicotine absorption. Water should be on hand; expelling saliva into a bowl is customary. Silence is essential during this phase. The recipient remains seated, breathes calmly and observes the inner experience without judgement. The main effects typically subside after 5–20 minutes. 5. Closing and Gratitude After the integration phase, typically only a few words are exchanged — a brief sharing of the experience, a word of thanks to the plant, the tradition and the people who have preserved the knowledge. If appropriate, further incense follows, or — within corresponding ceremonial frameworks — another plant medicine. Tepi vs. Kuripe: A Comparison of Tools Tool Application Context Tepi Long curved pipe; a second person blows Rapé into the recipient's nostril Ceremonial, partner-based; traditionally considered a more intense experience due to the external force of the facilitator Kuripe V-shaped pipe; one opening at the mouth, the other at one's own nostril Personal practice, everyday or individual use; one's own breath determines the dosage Both tools have their legitimate place. The Tepi is the classic ceremonial instrument — the transmission through another person is regarded in many traditions as essential, because it embodies trust, presence and connection. The Kuripe allows for a self-directed, regular practice without a facilitator. Further information on selecting, cleaning and handling both tools: Tepi & Kuripe — Tools of Rapé Practice. Rapé in the Context of Other Plant Medicines In the traditions of origin, Rapé rarely stands alone. It is frequently part of a continuum of ritual practices: Before and after Ayahuasca: Rapé serves for grounding and centring before an Ayahuasca ceremony, as well as for recollection and grounding afterwards. This combination is widespread in Santo Daime, União do Vegetal and in many neoshamanic circles. With Sananga (eye drops from Tabernaemontana undulata): A common sequence in Huni Kuin and Yawanawá contexts: Rapé for centring, then Sananga for "cleansing of sight." Both plants produce intense but brief sensations. With Kambo (frog secretion of the giant monkey frog Phyllomedusa bicolor): Rapé is occasionally used before a Kambo session for concentration and focusing. With Mambe (roasted coca leaf powder): In peoples such as the Uitoto and other Colombian groups, Mambe is used during long community conversations and council gatherings together with Rapé. ⚠️ Important Safety Notice: The combination of Rapé with MAO-inhibiting plants — in particular Ayahuasca (Banisteriopsis caapi) and Iboga — creates specific pharmacological interaction risks. Nicotine is partially metabolised via MAO-A; when MAO breakdown is inhibited, elevated nicotine levels in the blood may occur. Such combinations should take place exclusively under the guidance of experienced, qualified facilitators with prior medical consultation. When a Rapé Ceremony Is Contraindicated Rapé contains highly concentrated nicotine from Nicotiana rustica — with a nicotine content estimated to be five to ten times higher than in commercial tobacco blends. This is not marginal information; it is the central pharmacological fact that underlies the following contraindications: A traditional kuripe — the V-shaped pipe used for self-administering rapé. Cardiovascular conditions: Coronary heart disease, cardiac arrhythmias, uncontrolled high blood pressure — the acute nicotine load may trigger critical reactions. Pregnancy and breastfeeding: Nicotine crosses the placenta and is demonstrably embryotoxic. Absolutely contraindicated. Use of MAO inhibitors: Both classical antidepressants and plant-based MAO inhibitors (e.g. the Ayahuasca combination) may give rise to interactions. Use of certain SSRIs and anticoagulants: A medical consultation is strictly required in these cases. Acute psychiatric crises: In cases of active psychosis, severe dissociation or acute suicidality, a ceremonial framework without therapeutic support is not appropriate. First experience alone without a facilitator: Anyone applying Rapé for the first time should not do so alone. The intensity of the sensations and possible cleansing reactions require experienced accompaniment. A detailed overview of the pharmacology of effects and associated risks is provided in our article: Rapé Effects — What Happens in the Body? Finding an Authentic Facilitator In Europe — including Germany — there are facilitators who offer Rapé ceremonies, frequently in circles associated with Ayahuasca and consciousness work. The legal situation is nuanced: Rapé itself is legal in Germany (Nicotiana rustica and wood ash blends are listed in neither the BtMG nor the NpSG), yet ceremonial frameworks often exist in an institutional grey area, as they are not clearly regulated either as therapy or as a spiritual service. More detail on this can be found in the article on the Rapé Legal Situation in Germany. The following characteristics suggest a reputable facilitator: Verifiable connection to indigenous teachers: Training or long-term Dieta practice in Yawanawá, Huni Kuin or Kuntanawa lineages is a positive sign. Their own multi-year practice with an ongoing teacher relationship — not self-taught via YouTube. Binding contraindication screening before the ceremony — in writing or through a thorough conversation. No promises of healing: Rapé does not heal. Reputable facilitators state this clearly. No charismatic hierarchy issues: Excessive power imbalances, group dynamics or financial opacity are red flags to watch for. Consent and self-determination: The recipient may decline or stop at any time. This is non-negotiable. Rapé in Self-Application with the Kuripe Many people also practise Rapé alone — with the Kuripe, in a self-created morning stillness, as part of a personal meditation or reflective practice. This is possible and can be meaningful, provided certain points are observed: Respectful engagement means keeping the plant's origins in mind even during solo practice. Intention remains central. Anyone using Rapé as a quick "reset button" between appointments has left the ceremonial logic behind. Routinisation and risk of dependence: Nicotine is one of the most addictive psychoactive substances known. Anyone applying Rapé multiple times daily runs the risk of developing a nicotine dependence that has become entirely detached from the ceremonial context. Regular reflection — Why am I using Rapé today? How often? With what effect? — is therefore not an optional form of self-reflection, but a necessary corrective. The Rapé Collection at amama Collection Rapé Rapé is a sacred Amazonian shamanic snuff — a fine powder traditionally made from Nicotiana rustica tobacco combined with the ashes of various medicinal trees. Used for centurie… → Shop the collection Our selection Rapé Rapé is a sacred Amazonian shamanic snuff — a fine powder traditionally made from Nicotiana rustica tobacco combined with the ashes of various medicinal trees. Used for centuries by indigenous peop… Imdurana Rapé Extract Sold out Parica Rapé Extract Sold out Caneleiro Rapé Extract From €5.00 → Shop the collection amama carries a carefully curated selection of traditional Brazilian Rapé extract blends — including Caneleiro Rapé Extract, Parica Rapé Extract and Imdurana Rapé Extract. All products are offered as ethnobotanical collector's items for educational and research purposes, not for medicinal or commercial tobacco purposes. Further information on the product range: Rapé Buy Guide — What to Look For and Rapé Varieties Overview. Back to the Overview ← Back to the Rapé Guide · Rapé Effects · Experience Reports · Tepi & Kuripe · Legal Situation Last updated: April 2026. This content is for informational purposes only and does not constitute medical advice. Rapé contains nicotine in high concentration. For health-related questions, consult a medical professional. Further Reading Rapé Guide Rapé Effects Rapé Experience & Risks → Nicotine Compound Profile — chemistry & pharmacology
Learn moreRapé Effects: Pharmacology, Sensations and Duration
This article is part of our Rapé Guide. TL;DR — The Key Points at a Glance The primary active compound is nicotine from Nicotiana rustica (Mapacho) — which contains 5–10× more nicotine than commercial tobacco. Effects onset within seconds — nasal absorption through the mucous membrane is significantly faster than the oral or inhalation route. Two phases: an acute phase (0–5 minutes, intense physical sensations) and an afterglow (5–30 minutes, grounding and focus). Physical and mental effects: increased heart rate, mental stillness, grounded concentration, possible emotional release — no hallucinations, no psychedelic effect. Safety note: Rapé contains highly concentrated nicotine. Contraindicated in heart conditions, pregnancy, MAO inhibitors and certain SSRIs. Pharmacology: How Rapé Works in the Body Nicotine as the Primary Active Compound The pharmacologically most significant component of Rapé is nicotine — a naturally occurring alkaloid of the plant Nicotiana rustica, known in many Amazonian traditions by the name "Mapacho." While commercial tobacco varieties (Nicotiana tabacum) typically have a nicotine content of 1–3%, N. rustica reaches values of up to 9–14%. This represents a 5- to 10-fold higher concentration — a difference that is fundamental to understanding the intensity of Rapé's effects. Nicotine acts primarily as an agonist at nicotinic acetylcholine receptors (nAChR), which are widely distributed in both the central and peripheral nervous systems. Binding to these receptors triggers a cascade of physiological responses: Activation of the sympathetic nervous system: Heart rate and blood pressure rise briefly; adrenaline and noradrenaline are released from the adrenal glands. Dopamine release in the mesolimbic system: Nicotine stimulates the brain's reward system — this is experienced in the tradition as an intense "reset" moment in which the stream of thought momentarily ceases. Increased cortical arousal: nAChR activation in prefrontal regions is associated with enhanced capacity for concentration and readiness to respond. The Role of Tree Ash: pH Modulation and Absorption Kinetics A pharmacologically significant but often overlooked component of Rapé is the ash of various trees — Tsunu, Caneleiro, Murici, Pau Pereira, Cumaru and others, depending on the tradition and producing community. This ash is not an inert filler. Tree ash is strongly alkaline and raises the pH of the Rapé powder. Nicotine preferentially exists in its free base form at higher pH — and it is precisely this form that is absorbed far more efficiently through mucous membranes. This principle is well known from tobacco research: it explains why traditional products such as snus or certain betel quids are deliberately buffered to be alkaline in order to optimise nicotine uptake. For Rapé, this means concretely: the addition of tree ash considerably accelerates and intensifies the absorption of nicotine through the nasal mucosa. Since the nasal mucosa is richly vascularised and presents a short diffusion distance to the bloodstream, the effects of Rapé onset significantly faster than with smoked or orally ingested nicotine. Further Alkaloids in Nicotiana rustica In addition to nicotine, N. rustica contains further alkaloids in smaller concentrations, including anabasine and nornicotine. Both also bind to nAChR, albeit with lower affinity than nicotine. Their pharmacological role in the overall picture of Rapé's effects has not yet been systematically investigated. Some authors suggest that the interplay of these compounds contributes to the characteristic quality of the effect — however, this remains speculative and cannot currently be substantiated. From the archive Nicotiana rustica — Aztec tobacco (mapacho) Nicotiana rustica in flower — the Amazonian "mapacho" tobacco used as the base for traditional rapé. Wikimedia Commons · CC BY-SA What Users Report: Effect Phases in Practice The following descriptions are based on anecdotal reports from users as well as on transmitted interpretations of indigenous communities of the western Amazon — including the Yawanawá, Huni Kuin, Kuntanawa, Nukini and Katukina. These are neither clinically validated statements nor therapeutic promises. Pyridine alkaloid · Nicotiana rustica & N. tabacum nicotine 3-[(2S)-1-methylpyrrolidin-2-yl]pyridine Molecular formula: C10H14N2 Molecular weight: 162.23 g/mol CAS: 54-11-5 Compound profile: nicotine → Phase 1 — Acute (0–5 Minutes) Immediately after application, most users report a sequence of intense sensations: Intense pressure in the nasal mucosa and forehead region: The powder exerts an immediate physical presence. Many describe this as a wave that rises and spreads through the head. Brief silencing of thoughts: Users report a moment of mental stillness — an interruption of the internal stream of dialogue. In the tradition of the Yawanawá and Huni Kuin, this is interpreted as a "cleansing of the mind" or grounding into the here and now. Autonomic reactions: Increased heart rate, mild sweating, salivation and increased tear production are common. These reactions are a direct consequence of nicotine-mediated sympathetic activation. Mild nausea or dizziness (particularly on first use): In numerous Amazonian traditions, this effect is interpreted as "Limpieza" — spiritual cleansing. Pharmacologically, it is a classic nicotine-induced reaction, caused by activation of nAChR in the vomiting centre of the medulla oblongata. Phase 2 — Afterglow (5–30 Minutes) After the acute phase subsides, users frequently describe a characteristic state: Grounded, focused experience: Consciousness feels clearer, attention more stable. Many report a feeling of "settling" — as though inner restlessness had dissolved. Reduced mental "noise": Thought spirals or rumination temporarily decrease. This effect can be pharmacologically linked to nicotine-mediated modulation of prefrontal nAChR, though it remains individually variable. Possible emotional release: Some users report an emotional release — crying, a feeling of gratitude, or a sense of relief that is difficult to put into words. In ceremonial contexts, this is actively acknowledged as part of the healing process. Gradual normalisation of circulation: Heart rate and blood pressure slowly return to baseline values. Important note: Rapé is not a psychedelic. Neither hallucinations nor visual distortions nor altered states of consciousness in the sense of classical psychedelic substances occur. The effects remain physical and mental — intense, but grounded. Comparison with Other Nicotine Products Property Rapé (N. rustica + ash) Snuff (commercial) Cigarettes (N. tabacum) Snus Nicotine concentration Very high (5–10× N. tabacum) Medium Medium-low Medium-high Route of absorption Nasal (mucous membrane) Nasal (mucous membrane) Pulmonary (lungs) Oral (mucous membrane) Onset of effects Very fast (seconds) Fast (a few minutes) Fast (seconds) Slow (minutes) Intended use Ceremonial / traditional Recreational Recreational Recreational Typical duration of effect 5–30 minutes 30–60 minutes 5–15 minutes 30–60 minutes Addiction potential High (nicotine) High High High This comparison makes clear: compared with most commercial nicotine products, Rapé has a higher nicotine load combined with very rapid absorption — a combination that demands the mindful, conscious and respectful handling that indigenous traditions have emphasised for generations. Effect Profiles by Variety Within the diverse world of Rapé blends, experienced users report characteristic qualitative differences depending on the tree ash used and any additional plants. These assessments are anecdotal in nature and not pharmacologically standardised — they reflect the accumulated experience of users and the oral traditions of the respective producing community: Caneleiro: Described as mild and gentle; said to produce an even, lightly energising afterglow. Frequently recommended as an accessible introduction. Parica: Users report a pronounced focus effect, clear thought structure and a certain sharpness of perception. Imdurana: Described as warming and deeply grounding; frequently used in connection with meditative practices or prayer. Tsunu: Considered the "classic" Rapé variety — balanced, powerful, traditionally used in a wide range of contexts. Murici: Clarifying and sharp in sensation; users associate this variety with a distinct moment of cleansing. The variability of effect profiles is pharmacologically explained by two factors: the differing alkalinity of the respective ash (with a direct influence on nicotine uptake and kinetics) and possible secondary compounds from the plant materials used — the latter being scientifically barely investigated. A detailed overview of varieties and their traditional backgrounds is provided in our article Rapé Varieties: An Overview. Our selection Rapé Rapé is a sacred Amazonian shamanic snuff — a fine powder traditionally made from Nicotiana rustica tobacco combined with the ashes of various medicinal trees. Used for centuries by indigenous peop… Traditional mapacho (Nicotiana rustica) preparation in the Peruvian Amazon. Imdurana Rapé Extract Sold out Parica Rapé Extract Sold out Caneleiro Rapé Extract From €5.00 → Shop the collection Dosage and Course of Effects Ceremonial dosage is guided by the transmitted practices of indigenous Amazonian communities: typically one small portion per nostril — approximately comparable in quantity to a grain of rice or less. For first-time users, even significantly smaller amounts are recommended in order to assess the body's individual response. Application is made exclusively using two traditional tools: Tepi: A long, curved blowpipe section through which a second person blows the Rapé into the nostrils of the recipient. In ceremonial contexts, this is the preferred method, as it encompasses trust and relational connection. Kuripe: A V-shaped pipe for self-application — the user directs the powder with a single breath from the mouth into both nostrils simultaneously. Rapé is not smoked, not swallowed and not consumed in any other way. The exclusively nasal application is an integral part of ceremonial practice and pharmacologically significant for the course of effects. A complete guide to handling both tools can be found in the article Tepi and Kuripe: Application and Meaning. Safety Notes: What Must Be Observed ⚠️ Contraindications — please read carefully before use Due to the high nicotine concentration in Rapé, clear contraindications exist: Heart conditions and high blood pressure: Nicotine acutely and markedly increases heart rate and blood pressure. Rapé is not suitable for individuals with existing cardiovascular conditions. Pregnancy and breastfeeding: Nicotine crosses the placental barrier and passes into breast milk. Any form of nicotine exposure is contraindicated during these phases of life. MAO inhibitors (e.g. harmala alkaloids in Ayahuasca, certain antidepressants): The combination of nicotine with MAO inhibitors can lead to dangerous blood pressure spikes and cardiovascular reactions. In many Amazonian ceremonies, Rapé is traditionally used before the intake of Ayahuasca — nevertheless, caution is always warranted and medical consultation is strongly recommended in any case of doubt. Certain SSRIs and other psychoactive medications: Interactions are possible. In case of doubt, seek medical advice before use. Acute Reactions: What to Do Nausea, dizziness and heavy salivation on first use are common and are regarded in the tradition as part of the cleansing process. Pharmacologically, they reflect the response of a nervous system unaccustomed to nicotine. The recommendation: remain seated calmly, breathe consciously, spit out the saliva (do not swallow). If the reaction persists or is severe, use should be discontinued immediately. Addiction Potential Nicotine is one of the most strongly addictive psychoactive substances known. This risk exists regardless of the route of administration — regular nasal use can also lead to nicotine dependence. The traditionally ceremonial, non-everyday use of Rapé in the communities of origin is no coincidence: it protects against habituation and preserves the sacred character of the plant. More on user experiences, risks and cultural context: Rapé Experiences and Risks. On the legal situation in Germany: Rapé and German Law. Back to the Overview ← Back to the Rapé Guide · Ceremony and Application · Varieties: An Overview Last updated: April 2026. This content is for informational purposes only and does not constitute medical advice. Rapé is not a medicinal product and is not intended for the diagnosis, treatment or prevention of any disease. What Users Report — Anecdotal Themes from Erowid & Reddit The following synthesises recurring themes from Erowid experience reports and community discussion on Reddit (r/RapeHead, r/Ayahuasca, r/PsychonautRoundtable). These are self-reported, hedged accounts — not clinical findings. Common themes in first-person reports Immediate "reset" sensation: Many users describe a sharp pressure followed by a sudden mental quieting — "like a hard reboot for the head" is a common phrasing on Reddit. Emotional release: Spontaneous tears, sighs, or yawning are frequently mentioned, even outside of formal ceremony — interpreted in indigenous traditions as limpieza (cleansing). Post-effect clarity: A 20-60 minute window of "settled" focus after the acute peak is widely reported, with users describing it as conducive to journaling, meditation, or quiet conversation. Variety between blends: Erowid reports often emphasise that the differences between Caneleiro, Parica, and Tsunu blends are "real and noticeable" — not a placebo effect, but tied to specific sensations and intensities. Physical reactions: Increased heart rate, sweating, occasional nausea, and tearing up are described as normal first-time responses; reports consistently flag that these subside within minutes. Caveats raised by the community The nicotine dose is significant. Users with low nicotine tolerance report stronger vegetative responses — this is consistently framed as "respect the medicine, start small." Reddit threads regularly warn against routine, casual use; the consensus is that rapé works best in intentional, ceremonial contexts. Multiple Erowid reports stress combining rapé with MAOI-containing plants (ayahuasca, syrian rue) without expert facilitation as risky — and recommend medical clearance for anyone with cardiac concerns. Note: These themes are paraphrased from publicly accessible discussion; we do not link to specific reports to protect contributor anonymity. Read the source communities directly to form your own picture. Further Reading Rapé Guide Rapé Ceremony Rapé Varieties Rapé Experience & Risks → Nicotine Compound Profile — chemistry & pharmacology
Learn moreRapé: The Ultimate Guide to Sacred Amazonian Snuff
TL;DR — The Key Points at a Glance Rapé (pronounced "ha-PEH") is a traditional shamanic snuff from the western Amazon Basin, used for centuries by indigenous peoples in ceremonial and spiritual contexts. It is not smoked, but blown into the nasal cavity through specially crafted pipes — the tepi or kuripe. What it is: A finely ground mixture of Nicotiana rustica (mapacho tobacco) and the ash of various sacred Amazonian trees — not an ordinary tobacco product. Origin: Western Amazon Basin — Acre (Brazil), Peru, Colombia — rooted in the traditions of the Yawanawá, Huni Kuin, Kuntanawa, Katukina, Apurinã, and other peoples. Main ingredients: Nicotiana rustica (mapacho) as the primary nicotine carrier, tree ash as an alkaline vehicle and bearer of tradition, and occasionally additional medicinal plants. Application: Exclusively nasal — administered with the tepi (ceremonial pipe, blown by a second person) or the kuripe (V-shaped pipe for self-application). Traditional significance: Grounding, spiritual cleansing, focus, prayer, healing rituals — not a recreational substance, but a sacred medicine of indigenous peoples. Legal status in Germany: Rapé blends are legal in Germany — Nicotiana rustica and tree ashes are listed neither in the BtMG nor in the NpSG. It is sold as a traditional ethnobotanical. Availability at amama: amama.space offers three traditional rapé extracts from Brazilian sources: Caneleiro, Parica, and Imdurana. From the archive Nicotiana rustica — Aztec tobacco (mapacho) Nicotiana rustica in flower — the Amazonian "mapacho" tobacco used as the base for traditional rapé. Wikimedia Commons · CC BY-SA What Is Rapé? Rapé — correctly spelled with an accent over the "e", pronounced "ha-PEH" — is a fine, dry powder made from ground Nicotiana rustica and the ash of various sacred Amazonian trees. The term derives from the Portuguese word for snuff. In the English-speaking context, it is important to note that "Rapé" (with accent) refers to this ceremonial plant preparation — it should not be confused with the English word "rape" (without accent), which denotes sexual violence. The correct spelling with the accent is not a mere formality in this context, but a matter of respect toward the cultural origins of the preparation. Shop rapé at amama: Browse our Rapé collection → — Caneleiro, Parica & Imdurana extracts, traditional Amazonian blends. Rapé is not tobacco in the Western sense. When people think of snuff, they may picture a sterile, sprinkle-on powder passed around the salons of 18th-century Europe to stimulate the nasal mucosa. Rapé is something fundamentally different: it is a complex, handcrafted plant preparation made by indigenous masters (pajés or curandeiros) according to traditional recipes — sometimes the result of days of ritually accompanied work. Every blend carries the character of the tree used, the land in which it grows, and the intention of the maker. The pharmacologically most active component of rapé is nicotine. Nicotiana rustica — the tobacco species used in rapé, also known as "mapacho" — contains an estimated five to ten times more nicotine than commercially cultivated Nicotiana tabacum, the species processed in commercial cigarettes. This makes rapé a pharmacologically highly potent preparation that should not be handled carelessly. At the same time, rapé is more than the sum of its chemical components. In the traditions of the peoples who created it, it is a tool for inner alignment, spiritual cleansing, and communication with the plant world. This dual horizon — the biophysical and the sacred — is indispensable for understanding rapé adequately. Origins: The Indigenous Traditions of the Amazon The Western Amazon Basin as the Region of Origin The geographic home of rapé is the western Amazon Basin, with a focus on the Brazilian state of Acre, as well as adjacent regions of Peru and Colombia. This region is one of the most biologically and culturally diverse on Earth — and simultaneously one of the most threatened. The peoples who developed and preserved rapé traditions are numerous and culturally distinct. The best known include: Yawanawá (Acre, Brazil) — one of the most thoroughly documented peoples in the international neo-shamanic context; Yawanawá rapé is today one of the best-known varieties worldwide. Huni Kuin / Kaxinawá (Acre, Brazil) — one of the largest indigenous peoples of Acre, known for their work with ayahuasca (Nixi Pae) and rapé as a complementary medicine. Kuntanawa — a smaller people of Acre who are actively reviving their rapé tradition after a long period of cultural suppression. Nukini — also based in Acre, with their own rapé craft and botanical recipes. Apurinã — widespread along the Juruá River; their rapé tradition is closely connected with hunting rituals and the protection of territory. Katukina — known through their connection with kambo (Phyllomedusa bicolor) and an independent line of rapé. Shanenawa — a people of Acre with a strong revivalist movement in the area of traditional medicine. Matsés (Peru/Brazil) — known for unusual botanical mixtures; their rapé tradition differs significantly from the Acrean lines. Shipibo-Konibo (Peru) — a major ayahuasca tradition in which rapé plays a complementary role. It is crucial to emphasize: these peoples are not a monolithic group, and "rapé" is not a single uniform product. Each community has its own recipes, rituals, seasonal practices, and oral traditions. What they share is the basic structure — Nicotiana rustica and tree ash — as well as an understanding of rapé as a living, spiritual preparation. Pyridine alkaloid · Nicotiana rustica & N. tabacum nicotine 3-[(2S)-1-methylpyrrolidin-2-yl]pyridine Molecular formula: C10H14N2 Molecular weight: 162.23 g/mol CAS: 54-11-5 Compound profile: nicotine → How Rapé Came to Europe The spread of rapé beyond the Amazon began in the context of the globalizing ayahuasca movement of the 1980s and 1990s. Brazilian syncretic churches such as the União do Vegetal (UDV) and Santo Daime, which use ayahuasca as a sacrament, created international networks through which other Amazonian medicines also became known. During the 2000s, increasing numbers of European participants traveled to retreats in Peru and Brazil; many brought rapé home with them as part of their experience. Today rapé is well established in the European ethnobotanical community. In Germany — and especially in Berlin with its vibrant alternative culture — rapé can be found in ethnobotanical shops, at private ceremonies, and in professionally led medicine circles. amama.space, based in Berlin-Neukölln, sources its rapé products directly from Brazilian indigenous collectives and places emphasis on a traceable, ethical supply chain. Ingredients: What Is in Rapé? The composition of rapé appears simple at first glance, but is extraordinarily complex on closer inspection. Component Source Function Nicotiana rustica (mapacho) Traditionally cultivated, potent tobacco species Primary carrier of nicotine and minor alkaloids; pharmacological core Tree ash (e.g. Tsunu, Murici, Pau Pereira, Cumaru, Caneleiro, Imdurana, Parica) Burned bark, wood, or leaves of sacred trees Alkalizing the mixture; pH regulation of nicotine uptake; traditional "spirit" of the respective tree Optional medicinal plants Mint (Mentha spp.), ayahuasca vine (Banisteriopsis caapi), cumaru (Dipteryx odorata), and others Tradition- and blend-specific; aromatherapeutic or complementary components of effect Nicotiana rustica: Mapacho, the "Great Tobacco" Nicotiana rustica is not the tobacco plant known from cigarettes. It belongs to the same genus as the cultivated species Nicotiana tabacum, but is far superior to it in terms of nicotine content: while commercial tobacco products show nicotine concentrations of around 1–3% of dry weight, N. rustica typically contains between 9 and 14%. Some studies report values of up to 16%. In the Amazonian tradition, the plant is called "mapacho" — a term that conveys reverence and sacredness. Mapacho is not a recreational substance; it is a teacher. In shamanic contexts, it is regarded as an independent plant being with protective and cleansing properties. In addition to nicotine, N. rustica contains further alkaloids such as nornicotine and anabasine, whose pharmacological effects in the context of rapé remain insufficiently researched. For a detailed examination of the substance chemistry, see the nicotine substance article. The Tree Ash: Chemistry Meets Cosmology The ash is what makes rapé what it is. Without it, rapé would be nothing more than dried, pounded mapacho powder. The ash of specific trees is obtained by traditional methods: the bark or wood is burned, the ash collected, sifted, and ground. This process is ritually accompanied and shaped by a deep knowledge of the respective plants. From a purely chemical perspective, the ash acts as an alkaline vehicle: it raises the pH of the mixture, which promotes the release of free nicotine base from its salt form. Free nicotine base is absorbed through the nasal mucosa more rapidly and efficiently than the salt form. The same logic underlies the traditional coca practice, in which lime (from shell lime or limestone) is added to the coca leaf. From the perspective of tradition, the ash transfers the "spirit" of the tree — its protective quality, its character, its medicine. These two explanatory frameworks do not contradict one another; they describe different aspects of the same reality. Effects: What Do Users Report? Important note: The following descriptions are based on user reports and traditional oral traditions. They do not constitute medical statements and should not be understood as therapeutic claims. Rapé is not a psychedelic. It does not produce visual phenomena, altered states of consciousness in the sense of LSD or psilocybin, dissociation, or hallucinations. Anyone seeking rapé for these purposes will be disappointed — and should direct their focus elsewhere. What rapé does reliably produce are strong, immediate physical and psychological responses, which users frequently describe as profound. Immediate Phase of Effect (0–5 minutes) Within seconds of application, users report an intense feeling of pressure in the nose and sinuses — often described as a "reset" or "cleansing." The eyes water, the nasal mucosa responds with secretion, and in some cases brief coughing or gagging may occur. This phase is physically intense and can be uncomfortable, particularly during the first application. Simultaneously, a rapid rise in blood nicotine levels sets in, which may lead to an elevated heart rate, mild sweating, and increased saliva production. Nausea is possible at unfamiliar doses or in first-time users; in traditional contexts this is interpreted as purga — a cleansing reaction. Acute Phase of Effect (5–20 minutes) As the initial physical intensity subsides, many users report a state of heightened mental clarity, presence, and grounding. Thoughts that had previously been circling or flooding the mind seem to settle. Some describe a sharpening of sensory perception; others describe emotional relief, including brief bouts of crying that are subsequently experienced as cathartic. Studies suggest that nicotine binds to nicotinic acetylcholine receptors in the brain, thereby briefly modulating attention and cognitive acuity. The speed of the nasal absorption route — compared, for example, with smoking — may contribute to the particular quality of rapé's effects. Residual Phase (30–60 minutes) Many users describe a baseline feeling of calm, focus, and presence persisting for up to half an hour to a full hour after application. This phase is often experienced as the genuinely valuable meditation time — the period in which silence, prayer, or inner work seems particularly accessible. The complete, differentiated article on effects can be found here: Rapé Effects — Detailed Overview. The Rapé Ceremony Rapé in a ceremonial context is far more than the administration of a substance. In the traditions of the Yawanawá, Huni Kuin, and related peoples, the rapé ceremony is a sacred act — a moment of alignment between person, plant, and the invisible fabric of nature. Ceremonial rapé applications frequently take place within larger medicine frameworks — before or after ayahuasca ceremonies, for grounding after intense inner processes, as a standalone healing session, or as preparation for important decisions and life situations. Context (set and setting) is just as significant as the substance itself. Experienced facilitators (curandeiros, pajés, or trained ceremony leaders in the European context) work with the tepi — the long, gently curved ceremonial pipe — and administer rapé to participants with corresponding intention, preparation, and aftercare. Between the one who administers and the one who receives, a ritually bound connection arises that many participants experience as deeply meaningful. For more on the ceremony, preparation, integration, and ethical aspects: Rapé Ceremony — Full Guide. Application: Tepi and Kuripe Rapé is applied exclusively nasally — never smoked, eaten, or drunk. There are two traditional tools for application: The Tepi (Ceremonial Pipe) The tepi is a long, gently curved pipe, typically crafted from bamboo, bone, or reed. One person — the giver — fills one end of the tepi with a small portion of rapé, places it against the nostril of the receiving person, and blows the substance into one nasal opening with a single, focused, calm breath. The same is then done for the other side. The tepi is the tool of ceremonial practice, of mutual giving and receiving. An important ethical rule: rapé is never blown without the explicit consent of the receiving person. Surprise applications are unacceptable from both a traditional and a modern ethical perspective. The Kuripe (Self-Application Pipe) The kuripe is a V-shaped pipe that allows rapé to be self-administered: one end is held to the nostril, the other to the mouth. A focused exhalation propels the substance into the nasal cavity. The kuripe is the tool of personal practice — for meditation, morning rituals, or those moments when no tepi partner is present. On dosage guidance: Rapé portions are small — comparable in volume to a small pine nut seed. For first contact, a cautious approach is recommended: less is more. Both nostrils should be served equally in order to maintain sensory balance. Detailed instructions and care for the tools: Tepi & Kuripe — Guide. Rapé Varieties: An Overview The variety of rapé blends is considerable. Each tree ash lends a blend its own character — in terms of aroma, energy, and the subjectively perceived quality of effect. The following are some of the best-known varieties: Caneleiro The ash of the caneleiro tree (Ocotea spp. or related Lauraceae) is considered mild and yet remarkably clear. Caneleiro rapé is described by many users as accessible and energizing — well suited as an introduction to morning rituals or meditation preparation. amama offers a Caneleiro Rapé Extract from the Brazilian tradition. Parica Parica (Schizolobium parahyba or also Virola species — depending on the tradition) belongs to the more concentrated, mentally activating varieties. In the Yawanawá tradition, parica rapé is particularly well known. Users report a sharpening, focusing character — well suited for directed inner work. amama offers a Parica Rapé Extract. Imdurana Imdurana rapé is considered warm, grounded, and body-centered. The ash of the imdurana tree (Brosimum acutifolium) lends the blend a heavy, rooting quality. Many users reach for imdurana after intense ceremonies or stressful periods as an anchor back into the body. amama offers an Imdurana Rapé Extract. Tsunu Tsunu (Platycyamus regnellii) is one of the most classic tree ashes and is found in many traditional rapé recipes. It is considered balanced — neither particularly stimulating nor heavy — and is often the first rapé people encounter in practice. Mapacho (Nicotiana rustica) tobacco leaves at the Takiwasi center, Tarapoto, Peru. Murici Murici (Byrsonima crassifolia) is known for its clarifying quality — particularly in the area of the head and upper respiratory tract. Murici rapé is traditionally associated with clarity, seeing, and mental order. A more in-depth comparison of all varieties can be found here: Rapé Varieties — Full Overview. Legal Status in Germany A frequently raised topic is the question of the legal classification of rapé in Germany. The answer is clear: Rapé blends are legal in Germany. Neither Nicotiana rustica nor the tree ashes used (tsunu, murici, caneleiro, parica, imdurana, and others) are listed in the Narcotics Act (BtMG) or the New Psychoactive Substances Act (NpSG). There are no sales prohibitions or possession restrictions for these plants and plant preparations as such. Important nuances: Nicotine itself is regulated in the context of tobacco products for smoker consumption by the German Tobacco Act and EU directives. Rapé does not fall into this category — it is a traditional ethnobotanical plant preparation used as a snuff powder, not a smoking product. amama.space sells rapé expressly as a traditional ethnobotanical for ceremonial or collector purposes, not as a tobacco product for smokers and not as a food or medicinal product. Due to the high nicotine content, sales are in practice restricted exclusively to adults (18+). The full legal analysis, including EU context and cross-border questions: Rapé Legal Status in Germany — Full Analysis. Safety and Risks ⚠️ Safety notice — please read in full before using rapé. Rapé contains very high nicotine concentrations. Nicotiana rustica surpasses commercially available tobacco in this regard by a considerable multiple. In people without nicotine tolerance, even a small portion may trigger intense autonomic reactions: racing heart, sweating, nausea, dizziness, and elevated blood pressure. These reactions are physically unpleasant and may, in rare cases, pose a risk in individuals with pre-existing conditions. Contraindications — Rapé is not suitable for: Heart conditions, cardiac arrhythmias, heart failure — the nicotine bolus delivered through nasal absorption is rapid and strong; cardiovascular strain cannot be ruled out. Uncontrolled high blood pressure — nicotine briefly elevates blood pressure and heart rate. Pregnancy and breastfeeding — nicotine crosses the placental barrier and is detectable in breast milk; there is a risk to the unborn child or newborn. Concurrent use of MAO inhibitors — this applies in particular to people who are about to participate in or have recently attended an ayahuasca ceremony (ayahuasca contains MAO inhibitors such as harmine and harmaline); the combination may significantly alter the nicotine profile. Certain SSRIs and other serotonergic substances — the interaction has not been fully researched; caution is advised. Epilepsy or a tendency toward seizures — high nicotine doses may theoretically influence the seizure threshold. Addiction Potential Nicotine is one of the most addictive substances known. Regular rapé use may build up a nicotinic dependency — even when the context is ceremonial. This is a serious limitation that is underrepresented in many neo-shamanic discourses. In traditional indigenous contexts, rapé is as a rule not consumed daily and without restraint; the embedding in ceremonial structures acts as a natural framework. Outside these structures, this framework is absent — full personal responsibility rests with the user. First Application: Recommendations Ideally, rapé should be experienced for the first time in a guided, safe environment — with an experienced person who is familiar with both the effects and the tools. Small portions, patience, no pressure, and sufficient time afterward for rest and integration. Buying Rapé: What amama Offers amama.space, based in Berlin-Neukölln, carries three traditional rapé extracts from Brazilian sources in its range. All products are sold as traditional ethnobotanicals — not as a tobacco product, not as a food, and not as a medicinal product. The products at a glance: Caneleiro Rapé Extract — mild, clarifying, accessible Parica Rapé Extract — focusing, activating, from a Yawanawá-adjacent tradition Imdurana Rapé Extract — grounded, warm, body-centered All blends come from collectives with a traceable supply chain to indigenous communities in Acre, Brazil. No synthetic additives, no industrial processing. Sales exclusively to adults. Our selection Rapé Rapé is a sacred Amazonian shamanic snuff — a fine powder traditionally made from Nicotiana rustica tobacco combined with the ashes of various medicinal trees. Used for centuries by indigenous peop… Imdurana Rapé Extract Sold out Parica Rapé Extract Sold out Caneleiro Rapé Extract From €5.00 → Shop the collection For the full product overview, prices, and availability: Buy Rapé at amama. A general buying guide with quality criteria and sources can be found here: Rapé Buying Guide — What to Look For. Experience Reports: How Do Users Describe Their First Encounter? Experience reports — sometimes called "trip reports," although this term is somewhat misleading in the case of rapé — can help calibrate expectations and provide a sense of the range of possible experiences. Users report everything: brief, intense moments of clarity; experiences of emotional liberation; plain physical nausea with no spiritual dimension whatsoever; and deep silence. One's own experience is always individual and unpredictable. Context, disposition, dose, blend, and the presence of an accompanying person all play a role. Selected, annotated experience reports can be found in: Rapé Experience Reports. Related Topics from the amama Universe Rapé is part of a wider world of traditional botanical substances that amama curates and documents. If you would like to broaden your horizons: **Iboga — The Ultimate Guide**: Tabernanthe iboga is the sacred plant of the Bwiti tradition in Gabon and Cameroon. A completely different botanical universe — but equally deep in its cultural roots. **Kratom — The Ultimate Guide**: Mitragyna speciosa from Southeast Asia — traditionally used by workers and in healing contexts, today one of the most widely discussed ethnobotanical substances in Europe. **Blue Lotus — The Ultimate Guide**: Nymphaea caerulea, the sacred plant of ancient Egypt — for meditative and relaxing contexts. Frequently Asked Questions (FAQ) Is rapé the same as ordinary snuff? No. Ordinary snuff (such as snus, naswar, or European snuff tobacco) is an industrial product made from Nicotiana tabacum with added substances. Rapé is a handcrafted, traditional plant preparation made from Nicotiana rustica and tree ash — without industrial additives, developed within a cultural and ritual context. Can I use rapé daily? From a pharmacological perspective, daily use carries considerable addiction potential due to the high nicotine content. From a traditional perspective, rapé is a ceremonial tool, not a daily ritual — at least not in the doses and with the intensity of a first application. Many people who work with rapé report a gradual integration over time into gentle morning or meditation rituals — using very small portions, with a substantial interval since the last application. This is a question of personal maturity, not a general recommendation. Can I combine rapé with ayahuasca? Rapé is frequently used in combination with ayahuasca in traditional contexts — for grounding, cleansing, and focusing. At the same time, ayahuasca contains MAO inhibitors (harmine, harmaline) that may influence the metabolism of nicotine. Anyone attending ayahuasca ceremonies should discuss this question with the experienced facilitator leading the ritual. Self-directed, uncontrolled combination is not advisable. Where can I buy rapé in Berlin? amama.space, based in Berlin-Neukölln and with an online shop at amama.space, is one of the few German addresses offering ethically sourced rapé from traditional Brazilian sources. In addition, there are European ethnobotanical mail-order suppliers. A full guide can be found here: Rapé Buying Guide. Does rapé have a taste? Rapé has an earthy, partly bitter, partly smoky taste — depending on the tree ash. Since it is applied nasally, the taste is less dominant than with oral preparations; however, many users report an aftertaste at the back of the throat (via the nasopharyngeal passage). This article is the central reference point for all rapé content on amama.space. In-depth treatments of individual topics can be found in the linked spoke articles: Effects · Ceremony · Tepi & Kuripe · Varieties · Legal Status · Buying Guide · Experiences Last updated: April 2026. This content is for informational purposes only and does not constitute medical advice. Rapé products from amama.space are sold as traditional ethnobotanicals for ceremonial or collector purposes — not as medicinal products, not as tobacco products for consumers within the meaning of the Tobacco Act, and not as food. Sales exclusively to persons aged 18 and over. Further Reading Rapé Effects Rapé Ceremony Rapé Legal Status Buying Rapé Rapé Varieties Rapé Experience & Risks → Nicotine Compound Profile — chemistry & pharmacology
Learn moreIboga Microdosing: A Beginner's Guide
Iboga Microdosing: A Beginner's Guide TL;DR – The essentials at a glance Iboga microdosing refers to taking very small, sub-perceptual amounts (usually 50–300 mg of root bark) of Tabernanthe iboga, without psychoactive effects. In contrast to the full ceremonial dose, microdose users report subtle effects on mood, drive and concentration. In Germany, iboga (plant, powder, root bark) is not listed under the BtMG or NpSG and is therefore legally available; the isolated alkaloid ibogaine is subject to different rules in some EU countries. Common protocols follow the Fadiman schedule (1 day on, 2 days off) or shorter cycles with weekend breaks. Important: Iboga is cardiotoxic at higher doses and can interact with medications. Before any use, an ECG and liver panel check as well as medical consultation are advisable. Iboga microdosing is an emerging field – the scientific evidence base is limited, most knowledge comes from anecdotal reports. What is iboga microdosing? Iboga microdosing means regularly taking very small amounts of the root bark of Tabernanthe iboga – typically one tenth to one twentieth of a ceremonial dose. The goal is not a psychoactive experience but a sub-perceptual effect: you don't feel "high", but according to user reports, subtle changes in mood, energy or self-perception can be observed. The concept transfers the logic of psilocybin microdosing (popularised by James Fadiman) to the Central African iboga plant. While psilocybin microdosing has been discussed in the German scene for years, iboga is a relatively young trend – with its own pharmacological profile, its own protocols and a completely different risk structure. Iboga originally comes from Gabon, Cameroon and the Republic of Congo, where the root bark has been used ritually in the Bwiti tradition for centuries. In recent years, the plant has received attention in the West – initially through its use in clinical-experimental contexts around addiction, and now also in low-dose everyday applications. Anyone wanting to explore the plant in general can find a detailed overview in our Iboga Guide. Difference: Iboga vs. Ibogaine in microdosing A key point that many beginners confuse: iboga and ibogaine are not the same thing. Iboga (Tabernanthe iboga) is the plant – more precisely: the dried, powdered root bark. It contains a complex alkaloid mixture including ibogaine, ibogamine, ibogaline, tabernanthine and others. Ibogaine is the isolated main alkaloid, often available as ibogaine HCl (hydrochloride) in standardised pure form. For microdosing, this difference is crucial: Feature Iboga root bark Ibogaine HCl Alkaloid profile complex (multiple) isolated (ibogaine) Active content variable, usually 3–8 % total alkaloids standardised Legal status DE legal (not in BtMG/NpSG) regulated in some EU countries Typical microdose 50–300 mg powder 1–20 mg User reports gentler, "broader" effect more specific, sharper Many users prefer the root bark or TA extract (Total Alkaloid) for microdosing, because the full alkaloid spectrum is described as gentler and more balanced. Details on the legal classification can be found in our article on the Iboga Legal Status. How microdosing with iboga works Alkaloid profile of the root bark The root bark contains several pharmacologically active alkaloids which together produce a characteristic effect profile. Ibogaine is the best known, but depending on the batch it only makes up around 30–70 % of total alkaloid content. Other components such as ibogamine and tabernanthine are frequently described in user reports as mood-modulating. Mechanism (as far as known) Iboga alkaloids act on a broad spectrum of receptor systems – considerably broader than classical psychedelics such as psilocybin or LSD. The literature describes interactions with: NMDA receptors (glutamatergic system) Sigma receptors (Sigma-1 and Sigma-2) Opioid receptors (particularly kappa and mu, modulatory) Serotonin receptors (5-HT2A, 5-HT3) Dopamine and acetylcholine systems At microdose amounts, these effects are pharmacologically sub-threshold – users nevertheless report subtle shifts. Another discussed aspect is noribogaine, the active main metabolite of ibogaine, which has a long half-life (up to 28–49 hours) and partially accumulates with regular intake. Anyone wanting to delve deeper into the pharmacological basics can find further information in our article on Iboga Effects. Typical protocols from user reports Several microdosing schedules have become established in the community. None of them is scientifically validated – they are based on experiential knowledge and adaptations from the psilocybin context. 1. Fadiman-like protocol (3-day cycle) Day 1: Take microdose Day 2: Pause (observe after-effects) Day 3: Pause Day 4: Next microdose Duration: 4–8 weeks, then at least 2 weeks of complete pause. Particularly relevant for iboga, because noribogaine is slowly excreted. A 3-day interval is considered the minimum in user reports. 2. Stamets-like (5 days on, 2 days off) This protocol is critically discussed with iboga. Due to alkaloid accumulation, many users report overstimulation at this frequency. Most experienced users recommend longer pauses with iboga. 3. Weekend protocol Intake only Friday to Sunday, pause during the week. Variant: Only 1× per week, e.g. Saturdays. This schedule is preferred by users who want clear cognition without possible after-effects on working days. 4. Intuitive protocol Intake only on days when it feels desirable. Requires more self-observation but is described as more sustainable by experienced users. Community recommendation: Keep a microdosing journal. Note mood, sleep, heart rate (resting pulse), energy and side effects daily. Dosage notes from user reports Important note: The following figures come from user experience reports and from available grey literature. They are not a medical recommendation. Individual sensitivity, alkaloid content of the respective batch and physical condition lead to wide variation. Root bark (powdered) Starting dose: 50–100 mg Typical microdose: 100–250 mg Sub-perceptual upper limit: approx. 300 mg (above this, users frequently report noticeable effects) TA extract (Total Alkaloid) TA extracts are usually 8–15× more concentrated than the root bark. Typical microdose: 10–30 mg Popular because of the higher standardisation, but also less margin for error. Important rules Always start with the smallest possible dose. Better to start two cycles at 50 mg than to go straight in with 200 mg. Use a precise fine scale (0.01 g resolution) – kitchen scales are unsuitable. Take on an empty stomach, in the morning, with plenty of water. No combination with alcohol, other psychoactives, grapefruit juice or various medications (see risk section). Mind batch variability: Root bark batches can vary considerably. With every new package, start again at a low dose. A more detailed description of general iboga dosage (incl. higher ranges) can also be found in the Iboga Guide. Common reasons for iboga microdosing User reports paint various motivational pictures. We reproduce them without making any efficacy claims. Mood and emotional resonance Users frequently report a feeling of "emotional clarity" – less reactivity to everyday stresses, more inner distance from recurring thought patterns. Some describe iboga as "more grounding" than psilocybin microdosing. Focus and drive Some user reports mention improved concentration on individual tasks. Others report the opposite – a slowing down and more deliberateness. Individual variance is high. Pattern interruption and addictive behaviour Iboga is known in clinical-experimental research particularly for its possible use in opiate and stimulant dependence – there, however, in high, single flooding doses under medical supervision. In the microdosing context, users report easier interruption of habitual patterns such as nicotine, sugar or caffeine. Important: These reports are anecdotal. Microdosing is not a substitute for professional addiction therapy and we explicitly advise against replacing ongoing treatments on your own authority. Spiritual practice and self-reflection In the Bwiti tradition, iboga is considered a "teacher plant". Some users use microdoses alongside meditation, yoga or therapeutic work – as a subtle amplifier of their own practice, not as a replacement. Physical presence Unlike with psilocybin microdoses, iboga users frequently report a stronger physical component – a feeling of grounding, warmth or enhanced body awareness. Possible risks and precautions This is the most important section of this article. Iboga is pharmacologically considerably more demanding than psilocybin. Anyone ignoring this risks serious harm. Cardiovascular risk Ibogaine prolongs the QT interval of the heart. At high doses, this can lead to life-threatening cardiac arrhythmias. At microdoses, the risk is considerably lower but not zero – particularly with: Pre-existing heart conditions Electrolyte imbalances (low potassium, magnesium) Concurrent intake of other QT-prolonging substances Accumulation due to overly close dosing intervals Recommendation: Have an ECG done before starting and check electrolytes. Drug interactions Iboga alkaloids are metabolised mainly via CYP2D6. This affects a great many medications. Strict caution with: SSRIs, SNRIs, MAO inhibitors (antidepressants) Opiates and opioids Tramadol, codeine Antiarrhythmics Some antihistamines Grapefruit juice (CYP3A4 inhibition) Medical consultation is mandatory with any long-term medication. Liver There are individual case reports of elevated liver values in iboga users. Before and during longer microdosing cycles, regular liver value checks (AST, ALT, γ-GT) are sensible. Psychological contraindications Although microdoses are sub-perceptual, experience reports advise against iboga with the following pre-conditions: Acute psychoses or psychotic pre-existing conditions Severe bipolar disorders Untreated severe depression Pregnancy and breastfeeding Quality of source Root bark from dubious sources can be contaminated, incorrectly declared or pharmacologically composed differently than stated. Look out for: Botanical identification (ideally with batch certificate) Origin information Where possible, laboratory analysis of alkaloid content Vendors who offer transparency In our Iboga collection we carry exclusively tested products. No "set-and-forget" Microdosing does not mean: "set it once and forget it". Especially with iboga: observe carefully, take regular breaks, stop immediately if unwell. FAQ Is iboga microdosing legal in Germany? The plant Tabernanthe iboga (root bark, powder, capsules) is not listed in the German Narcotics Act (BtMG) and not in the NpSG and is therefore legally available. The isolated alkaloid ibogaine is subject to different regulations in some EU countries. Details can be found in our article on the Iboga Legal Status. How does iboga microdosing differ from psilocybin microdosing? Psilocybin acts mainly serotonergically (5-HT2A). Iboga has a considerably broader receptor profile and a more physical component. Users often describe psilocybin microdoses as "open and creative", iboga microdoses as "grounding and focused". In addition, iboga has a different safety profile (heart, liver). How long does a microdosing cycle last? Typical is 4–8 weeks, followed by at least 2–4 weeks of pause. Long continuous protocols without breaks are not recommended in user reports – both because of possible tolerance development and because of the accumulation of noribogaine. Can I combine iboga microdosing with antidepressants? No, not without medical clarification. Many antidepressants (SSRIs, MAO inhibitors) are metabolised via the same liver enzymes or interact serotonergically. The risk of adverse effects is real. Can I drive during microdosing? With a correctly chosen sub-perceptual dose, users report unimpaired reaction capacity. Nevertheless: Do not drive on the first day of use with a new batch or new dose. Test the individual reaction first on a free day. Which form is best for beginners – powder, capsules or extract? For beginners, many experienced users recommend capsules with pre-dosed powder or self-filled root bark powder. TA extracts require more experience due to the higher potency. Raw powder can additionally be stirred into juice (the taste is very bitter). When do you notice something? Many users report that subtle effects can occur as early as the first day, but clearer shifts (sleep quality, mood state) only after 2–3 weeks of regular cycles. Others feel little over weeks – individuality is normal here. Can you become dependent on iboga microdosing? Iboga alkaloids are not pharmacologically considered classically addictive – on the contrary, they are studied in addiction research for their potentially pattern-interrupting properties. A psychological habituation to the rhythm can nevertheless develop; regular pauses are sensible for this reason too. What to do about side effects? Mild nausea, head pressure or fatigue in the first days are possible and usually subside. In case of palpitations, irregular pulse, severe nausea or dizziness: stop immediately and seek medical help. Do not continue dosing under any circumstances. Does microdosing replace an iboga ceremony or therapy? No. The traditional Bwiti ceremony and clinical-experimental flooding applications are qualitatively different experiences with completely different efficacy and a different risk profile. Microdosing is an independent, subtle concept – not a watered-down ceremony. Related content If you would like to dive deeper into the iboga topic, we recommend our other articles: The comprehensive Iboga Guide → Ibogaine Compound Profile — chemistry, pharmacology & references
Learn moreIboga Retreat in Germany and Europe — 2026 Guide
Iboga Retreat in Germany and Europe — 2026 Guide TL;DR Iboga retreats in Germany exist but operate in a legal grey area: the plant is legal, therapeutic use without medical licensing is not. Reputable, clearly legal options can be found in the Netherlands (Tabula Rasa Wellness Center, Tyohar), Spain (Madera Sagrada, Barcelona) and Portugal. Medical screening is mandatory: ECG (QT interval), liver values, medication history. Iboga/ibogaine can trigger fatal cardiac arrhythmias in those with pre-existing conditions. Costs: reputable retreats cost €2,500–5,500, usually including pre-consultation, medical supervision, accommodation and integration. Warning sign: anyone who skips ECG, blood work and medical consultation is not a reputable provider — no matter how "traditional" the ceremony sounds. This guide does not replace medical advice. No dosage recommendations. Iboga is not a recreational substance. Anyone seriously considering a retreat — whether for opiate addiction, trauma, depression or existential reorientation — needs solid information, not a marketing brochure. This guide explains what iboga retreats are, where they are legally offered in Europe, how to recognise reputable providers and which medical prerequisites are non-negotiable. Iboga retreats: what they are and how they work An iboga retreat is a multi-day, guided ceremony or treatment using Tabernanthe iboga — a West African shrub whose root bark contains the alkaloid ibogaine. Broadly speaking, there are three formats: 1. Bwiti ceremonies (traditional-spiritual). Based on the Bwiti tradition of Gabon. The centrepiece is an initiation ritual with song, drums and administration of root bark by a Nganga (ceremony leader). Duration: 12–36 hours active phase, 3–7 days of retreat overall. 2. Psycho-spiritual retreats (Western hybrid). Combine iboga root bark or total alkaloid extract (TA) with Western integration methods: pre-consultations, breathwork, integration coaching. Common in Europe. 3. Ibogaine treatments (medical-clinical). Use isolated ibogaine hydrochloride, mostly for addiction interruption (opiates, stimulants, alcohol). Strictly medically supervised, with telemetry monitoring and cardiologists. The experience itself lasts between 12 and 36 hours depending on dose and protocol. Characteristic features include a "waking dream" phase with vivid visual and biographical content, a reflective phase, and a multi-day recovery period with persistently reduced need for sleep. Legal situation in Germany: plant legal, therapy in a grey area The iboga plant and its root bark are not listed under the Narcotics Act (BtMG) in Germany. Possession and acquisition of the plant parts are generally legal. Ibogaine as an isolated active substance is not approved as a medicinal product in Germany. This means: therapeutic use — i.e. an "iboga treatment" for addiction or depression by non-physicians — is problematic under medicines law. Anyone administering ibogaine is operating within the scope of the Medicines Act (AMG). Physicians can use ibogaine in individual cases within the framework of an individual therapeutic attempt, but this is legally and liability-wise complex and extremely rare. Iboga retreats in Germany therefore take place largely "underground": privately organised, without medical supervision, often without adequate medical screening. This is where most iboga-related deaths occur. Nearly all documented incidents involve settings without cardiac monitoring or with undetected contraindications. Our position at amama: We do not recommend "underground" retreats in Germany. Anyone seriously interested in an iboga experience should travel to an EU country with a clearer legal framework, where established providers work with medical protocols. More on this topic: Iboga legal situation in Germany. Legal situation in Europe: country comparison Country Iboga (plant) Ibogaine (active substance) Retreats Netherlands legal not approved as medicine, but tolerated yes, established Portugal legal tolerated, not regulated yes Spain legal not regulated yes Belgium legal unclear rare Switzerland plant legal, ibogaine prescription-only medical use possible limited Germany plant legal subject to AMG grey area France banned (since 2007) banned none The Netherlands is de facto the European centre of legal iboga work. Several centres have been operating here for over a decade with medical protocols and no legal incidents. Portugal offers a soft framework thanks to its general decriminalisation policy. Iboga is not actively prosecuted here. Spain provides a clear framework for Bwiti ceremonies thanks to its religious freedom regulations. France is a clear "no" market: iboga and ibogaine have been on the list of prohibited substances since 2007. Reputable retreats in Europe We deliberately list only providers who have been operating for years, enforce medical screening as mandatory, and are transparent about risks. No affiliate partnerships, no commissions. Tabula Rasa Wellness Center (Netherlands, Portugal) Locations in the Netherlands (near Amsterdam) and Portugal (near Lisbon). One of Europe's most experienced providers, active for over 10 years. Focus: ibogaine for addiction interruption and psycho-spiritual retreats. Medical team with anaesthetist/physician on site Mandatory ECG, blood count (incl. liver values), medication screening before arrival Cardiac monitoring during the active phase Structured pre- and post-consultation, integration programme Small groups (4–8 people), individual protocols Madera Sagrada (Barcelona, Spain) Traditionally oriented retreat centre with Bwiti ceremonies. Connection to the Gabonese tradition, Western-supported. Several ceremonies per year, small groups. Ceremonial framework with African facilitators Mandatory medical screening More spiritual-initiatory focus than clinical-addiction medical Tyohar / Awaken Healings (Netherlands) Holistic retreats in the Pijnacker/South Holland area. Combination of iboga work, meditation and integration coaching. Smaller, more intimate settings. Other reputable providers Iboga Wellness Center (Costa Rica) — outside Europe, but frequently booked by Europeans Beond (Cancún, Mexico) — clinical ibogaine setting, many veterans The common thread with all reputable providers: they will turn you down if your ECG or medication indicates against treatment. Anyone who takes you "anyway" is not reputable. What makes a good retreat How can you recognise quality — beyond website aesthetics? 1. Medical pre-screening. Mandatory 12-lead ECG (no older than 4–6 weeks), liver values (AST, ALT, GGT, bilirubin), kidney values, electrolytes (especially potassium, magnesium), blood count. Medication history including supplements. Reputable providers have the values reviewed by a physician, not just by the "facilitator". 2. Physician or nursing professional on site. During the active phase (first 24 hours), medical staff must be physically present. "A doctor on call" is not enough — QT prolongations develop within minutes. 3. Cardiac monitoring. At minimum continuous ECG monitoring during the acute phase. For ibogaine treatments: telemetry. 4. Individual dosing protocol. No standard dose "for everyone". Dose depends on body weight, indication, prior experience. 5. Structured integration. At minimum one follow-up consultation, ideally 4–12 weeks of integration coaching. The iboga experience continues to have effects for weeks; without integration, much potential fizzles out. 6. Transparent communication about exclusion criteria. Good providers state clearly on their website whom they do not treat. 7. References and track record. Established providers have existed for several years, have public testimonials and name their team qualifications. Red flags: anonymous team, no medical pre-examination required, groups over 10 people per facilitator, "money back if dissatisfied" promises, healing guarantees, dosage recommendations via WhatsApp. Medical preparation: ECG, contraindications, medications Iboga and ibogaine cause dose-dependent QT prolongation on the ECG. In predisposed individuals, this can develop into torsade de pointes arrhythmia — a potentially fatal cardiac arrhythmia. Most documented iboga deaths are attributable to this. Absolute contraindications (no retreat) Pre-existing long QT syndromes (congenital or acquired) Cardiac arrhythmias, structural heart disease Recent myocardial infarction, heart failure Severe liver or kidney insufficiency Active psychotic illnesses, schizophrenia, bipolar disorder in manic phase Pregnancy and breastfeeding Problematic medications (clarification mandatory) SSRIs, SNRIs, tricyclic antidepressants — multi-week, medically supervised discontinuation required MAO inhibitors — absolute contraindication Antiarrhythmics, certain antibiotics (macrolides, fluoroquinolones), antifungals — all potentially QT-prolonging Opiates/opioids — complex interaction, but intentional and monitored in addiction therapy Methadone has an extremely long half-life; switching to short-acting opiates before ibogaine is standard Examinations before departure 12-lead ECG (QTc calculation) Blood count, electrolytes (correct potassium, magnesium if low) Liver and kidney values For those over 40 or with cardiovascular risk factors: echocardiography, stress ECG Psychiatric evaluation in case of psychiatric history Good retreats actively request these values and refuse without them. More on medical aspects: Iboga therapy. Costs and what should be included Reputable iboga retreats in Europe cost €2,500–5,500 for 5–10 days. Clinical ibogaine treatments for addiction interruption are higher (sometimes €6,000–10,000). The price should include: Pre-consultation(s) and medical review Accommodation and meals during the retreat Medical supervision (physician/nursing staff, ECG monitoring) Iboga/ibogaine substance (verified purity) At least one integration session after the ceremony Additional costs to budget for: Travel (flight to Amsterdam/Barcelona/Lisbon) On-site blood draw or ECG, if German results are insufficient Longer-term integration coaching Possibly medication adjustment with your doctor in Germany If an offer is significantly below €2,000, you should be sceptical. Reputable medical personnel, small groups and genuine integration cannot be delivered below this price. Questions to ask before booking Take this list literally and send it to the provider. The answers will tell you more than any website. Who is medically on site? Name, qualification, hours of attendance. What pre-examinations do you require? (If none: abort.) How many participants per facilitator during the active phase? Do you use root bark, total alkaloid (TA) or ibogaine HCl? From what source? How is purity tested? How exactly is cardiac monitoring organised? (Single ECG, continuous monitoring, telemetry?) What does the emergency protocol look like? Distance to the nearest hospital, defibrillator on site? Which medications must I discontinue and when? Who supports me during this? Whom do you not accept? (Clear answer = good provider.) What does integration afterwards look like? Included? How often? Over what period? Which testimonials and references can you provide? Have there been medical incidents in your history? (Transparent providers answer honestly — no provider with decades of experience can claim "nothing ever happened".) What happens if I am not medically suitable shortly before the retreat? Refund policy? Current research: Stanford Study 2025 The study by Cherian et al. (Stanford, 2025) examined 30 US military veterans with traumatic brain injuries and PTSD following a supervised ibogaine treatment (in Mexico, since illegal in the USA). Results after one month: significant reduction of PTSD, depression and anxiety symptoms, improvement of executive functions. No serious cardiac incidents under strict cardiac monitoring with magnesium prophylaxis. The study is small, uncontrolled and selective — but it confirms what clinically operating retreat centres have been observing for years: under strict medical supervision, the therapeutic use of ibogaine is possible and shows remarkable signals in hard-to-treat indications. It is precisely this supervision that is lacking at underground retreats. FAQ Are there legal iboga retreats in Germany? The plant is legal, but therapeutic use without medical licensing operates in a grey area under medicines law. De facto existing retreats in Germany are mostly privately organised and work without a standard medical protocol. For a reputable experience, we recommend a retreat in the Netherlands, Spain or Portugal. How much does a reputable iboga retreat cost? €2,500–5,500 for psycho-spiritual retreats in Europe. Clinical ibogaine treatments for addiction interruption €6,000–10,000. Cheaper almost always means: without medical screening, without a doctor on site — you are saving at the wrong end. How dangerous is iboga really? Without medical screening, life-threatening — deaths are documented, nearly all in underground settings with undetected heart conditions or drug interactions. With proper pre-examination and cardiac monitoring, the risk is significantly lower, but never zero. Iboga is not a "wellness experience". Can iboga really help with opiate addiction? There is serious clinical and empirical evidence that ibogaine has a unique effect on opiate addiction — including largely suppressing acute withdrawal symptoms. However, studies are small and methodologically limited. An ibogaine treatment does not replace long-term addiction therapy, but can function as an "interruption". Do I have to stop my antidepressants? In most cases yes — SSRIs, SNRIs, tricyclic antidepressants and especially MAO inhibitors are contraindications or risk factors. Discontinuation must take place several weeks in advance and under medical supervision. Reputable retreats give you a protocol and require consultation with your treating physician. How long does the experience last? The acute phase 12–24 hours, with a vivid "waking dream" phase in the first hours. Then a reflective phase of several hours up to one day. Recovery and reduced need for sleep: 2–3 days. The psychological integration process runs over several weeks to months. Can I try iboga as a microdose instead of at a retreat? Iboga microdosing is a separate topic with a different risk profile (lower doses, but the same cardiac and medication warnings apply). It does not replace a therapeutic retreat ex → Ibogaine Compound Profile — chemistry, pharmacology & references
Learn moreBuying Iboga — What to Look For (Guide 2026)
Buying Iboga — What to Look For (Guide 2026) Iboga (Tabernanthe iboga) is a West African root bark with a long ritual tradition in Gabon and Cameroon. In Germany it is legally available — yet the market is opaque and quality varies enormously. This guide shows you what to pay attention to when buying iboga, which product forms exist, how to recognise reputable suppliers, and why lab analyses (COAs) are the central proof of quality. TL;DR — Buying iboga at a glance Iboga is legal in Germany — not controlled under BtMG or NpSG. Trade is permitted. Quality is decisive: authentic Tabernanthe iboga TA root bark from sustainable sources, ideally with a COA. Main forms: powder, capsules, whole/ground root bark, extract, and tincture — each with its own profile. COAs (Certificates of Analysis) document alkaloid content, identity, and purity (heavy metals, microbiology). Price orientation: powder from approx. €30–60/10 g, extracts and TA bark correspondingly higher. Reputability check: transparent origin, lab analyses, clear botanical designation, no healing claims. Is buying iboga legal in Germany? Yes. Iboga and its main alkaloid ibogaine are listed neither in the German Narcotics Act (BtMG) nor in the New Psychoactive Substances Act (NpSG). This means cultivation, possession, trade, and purchase of the plant and its preparations are fundamentally permitted. Unlike in the USA, France, Belgium, or Switzerland, there is no substance-law classification in Germany that restricts acquisition. Important to know: legal does not mean unregulated. As soon as a product is marketed as a medicinal product, food, or food supplement, other regulatory frameworks apply (LFGB, AMG). Reputable shops therefore sell iboga as a botanical sample or ethnobotanical collector's item — without healing claims, without dosage recommendations for human consumption. Details on the current legal situation — including international differences and travel aspects — can be found in our in-depth article on the legal status of iboga. Available forms: powder, capsules, root bark, extract, tincture If you want to order iboga, you will encounter five common product forms. They differ in processing, concentration, shelf life, and area of use (ritual, ethnobotanical, collector purposes). Iboga powder (ground root bark) Finely ground Tabernanthe iboga TA root bark. The TA designation (Total Alkaloid Root Bark) means the complete natural alkaloid spectrum is present — not just ibogaine, but also ibogamine, tabernanthine, and other secondary alkaloids. Buying iboga powder is the classic entry form: easy to measure, homogeneous, long shelf life when stored dry and dark. Iboga capsules (standardised powder) Powder in plant-based capsules (usually HPMC, occasionally gelatine). The advantage: consistent fill weight per capsule, no bitter taste, discreet handling. Anyone looking to buy iboga capsules should check for the alkaloid content per capsule — ideally confirmed by laboratory analysis. Capsules are particularly suitable for structured protocols. Iboga root bark (whole or coarsely ground) Whole bark pieces or shreds of TA root bark — the traditional form as used in the Bwiti ritual of Gabon. Visually recognisable by the characteristic yellowish-brown inner side and the light fibre pattern. Buying iboga root bark is the most authentic variant, but requires your own preparation (grinding, extraction) and presupposes appropriate knowledge. Iboga extract (concentrated alkaloid) An extract concentrated via solvent or water extraction. Extracts can be in the form of total-alkaloid extract (TA extract) or ibogaine HCl. The latter is highly pure (>98% ibogaine hydrochloride), usually as a white crystalline form. Extracts are considerably more potent than raw bark and are aimed at collectors who wish to document precise alkaloid quantities. Iboga extract is the product form with the highest purity and analytical requirements. Iboga tincture / iboga drops Alcohol- or glycerine-based extracts of the root bark. Tinctures offer a liquid, drop-accurate form of administration and keep well. Quality varies considerably: extraction medium, drug-to-extract ratio (DER), and alkaloid content should be clearly declared. A deeper overview of the activity spectrum and tradition can be found in the iboga guide. What distinguishes high-quality iboga products? The difference between a reputable and a questionable product is evident in several objective criteria: 1. Botanical identity. There are plants that can be confused with iboga, such as Voacanga africana, which look similar but have a different alkaloid profile. High-quality suppliers can confirm by HPLC or DNA analysis that the material is indeed Tabernanthe iboga. 2. Plant part. Only the root bark contains the desired alkaloid concentration. Stem wood, leaves, or mixed material are inferior. Reputable products are clearly declared as root bark or TA material. 3. Origin and sustainability. Iboga grows slowly. Wild harvesting in Gabon is under pressure — the CITES issue is being discussed internationally. Prefer suppliers who work with cultivated sources (e.g. from Cameroon, Ghana, or plantation projects) and provide proof of origin. 4. Alkaloid content. TA root bark typically contains 4–6% total alkaloids, 60–80% of which is ibogaine. Products with documented content are more transparent than those without analytics. 5. Processing and storage. Iboga should be gently dried, finely ground, and shipped in light-proof, airtight packaging. Moisture and UV light measurably reduce alkaloid content. 6. Freedom from contaminants. Heavy metals (lead, cadmium, arsenic, mercury), pesticide residues, and microbiological contamination (mould, E. coli) are real risks with unregulated raw material. Laboratory analyses are not optional here but mandatory. COAs and laboratory analyses: why they are decisive A Certificate of Analysis (COA) is the test protocol of an independent laboratory. For iboga it should show the following points: Identity: HPLC or HPTLC fingerprint confirming Tabernanthe iboga Alkaloid content: total alkaloids and ibogaine proportion in % or mg/g Secondary alkaloids: ibogamine, tabernanthine, ibogaline (profile confirms authenticity) Heavy metals: Pb, Cd, As, Hg — limits following EU pharmacopoeia logic Microbiology: total germ count, yeasts/moulds, pathogens Pesticides / residues: relevant depending on origin Batch number: traceability back to raw material Why this is central: Without a COA you are buying a black box. A brown powder can be anything — from genuine TA bark to adulterated Voacanga material. Ibogaine HCl that superficially looks white may be contaminated or underdosed. The laboratory report is the only objective quality criterion. At amama, laboratory analysis is standard: every iboga batch is tested for identity, alkaloid profile, and purity, and COAs can be viewed on request or via the product page. Typical price ranges by form (for orientation) The following price ranges are market observations for the German/European region 2025/2026. They serve as orientation — not as fixed prices. Product form Typical price range Iboga powder (TA root bark) approx. €30–60 / 10 g Iboga capsules (standardised) approx. €25–50 / 20–30 capsules Iboga root bark (whole/shreds) approx. €25–50 / 10 g Iboga extract (TA extract) approx. €60–150 / 5 g (depending on concentration) Ibogaine HCl (>98%) approx. €150–400 / 1 g Iboga tincture approx. €25–60 / 30–50 ml What influences the price? Origin (wild harvest vs. cultivation), alkaloid content, laboratory documentation, batch size, shipping costs, and customs handling. Strikingly cheap offers — especially from unclear online sources — are often a warning sign: either mixed-up material, old batches with degraded alkaloids, or unregistered grey imports. A fair price lies in the middle range. Those offering considerably less typically save on analytics, proof of origin, or purity. What to look for in online shops (reputability check) An iboga shop is only as good as its transparency. This checklist helps you distinguish trustworthy from problematic suppliers: ✅ Imprint and registered office in the EU. Clear company name, valid service address, VAT ID. Shops without an imprint should be avoided. ✅ Clear botanical designation. Tabernanthe iboga, part of the plant (root bark), country of origin. No fantasy names. ✅ COAs available. Either linked directly on the product page or viewable on request. Batch and date traceable. ✅ No healing claims. Reputable suppliers sell iboga as a botanical sample or ethnobotanical product — not as a therapy against addiction, depression, or other conditions. Anyone making such claims is operating in a legal grey area and signals unreliability. ✅ Transparent shipping and return conditions. T&Cs, right of withdrawal, shipping country. ✅ Reachable customer service. Email, ideally telephone. Response within a few working days. ✅ Payment methods with buyer protection. SEPA, credit card, PayPal. Exclusively crypto payment without alternatives is a warning sign. ✅ Age verification. Reputable ethnobotanical shops check for age of majority. ❌ Warning signs: no contact details, only crypto payment, absurdly low prices, healing claims, missing COAs, conspicuous spelling errors, stock photos as product images, "directly from Africa" without any analytics. The entire iboga collection at amama is curated according to these principles: botanically verified, lab-tested, transparently documented. Common mistakes when buying iboga 1. Putting price before quality. The difference between €40 and €25 per 10 g of powder is often the difference between tested TA bark and anonymous raw material. With such a complex plant, this is not a sensible saving. 2. Not requesting a COA. Many buyers never ask for laboratory analyses. Reputable suppliers provide them — a shop that evades this is a bad sign. 3. Confusion with Voacanga. Voacanga africana is occasionally sold as "iboga" but contains a different alkaloid profile (mainly voacangine, hardly any ibogaine). Not distinguishable without analytics. 4. Grey-market sources from social media. Offers via Telegram, WhatsApp, or closed forums bypass all quality control. Legally risky, health-wise incalculable. 5. Confusing ibogaine HCl with TA bark. Ibogaine hydrochloride is an isolated pure substance and has a completely different concentration profile than root bark. They are not interchangeable. 6. Incorrect storage after purchase. Iboga loses alkaloids through light, heat, and moisture. Storage: dark, dry, airtight, cool. 7. No engagement with interactions. Iboga has a relevant pharmacological interaction profile (including hERG channel, CYP2D6). Anyone interested in microdosing should read the iboga microdosing fundamentals before ordering. 8. Ignoring the ritual context. Iboga is not a lifestyle substance. Anyone acquiring it should know and respect the cultural background (Bwiti tradition, sustainability questions). FAQ 1. Is it legal to order iboga in Germany? Yes. Iboga and ibogaine are subject to neither the BtMG nor the NpSG in Germany. Import from EU countries is unproblematic; for third countries, customs may ask additional questions. 2. Which iboga form is best? "Best" depends on purpose. TA root bark / powder offers the complete alkaloid spectrum. Capsules are practical for structured protocols. Extracts are interesting for collectors who want precise concentrations. For newcomers to the topic, powder or capsules with a COA are the most transparent. 3. What is the difference between TA bark and ibogaine HCl? TA bark (Total Alkaloid Root Bark) contains the natural alkaloid spectrum (~4–6% total alkaloids). Ibogaine HCl is the isolated, crystalline main alkaloid at high purity (>98%). They are not pharmacologically identical and not 1:1 interchangeable. 4. How do I recognise a reputable COA? A genuine COA bears the name and accreditation of an independent laboratory, a batch number, an analysis date, and specific measured values (not just "passed"). Generic PDFs without a laboratory letterhead are worthless. 5. Can I also buy iboga in pharmacies? No. Iboga is not an approved medicinal product in Germany and is therefore not distributed via pharmacies. Sales take place exclusively through specialist ethnobotanical retailers. 6. How long does iboga keep? With correct storage (dark, dry, airtight, cool), TA powder retains its alkaloid content for at least 2–3 years. Extracts and ibogaine HCl are stable even longer under the same conditions. Moisture and UV are the biggest enemies. 7. Are there reputable iboga retreats in Germany or Europe? In Germany there are no classic iboga retreats, as therapeutic offerings are legally restricted. In parts of Europe (e.g. the Netherlands, Portugal) there are providers with medical supervision. Selection requires thorough research — medical screening (ECG, liver values, medication review) is non-negotiable. 8. Why is amama a reputable source? amama is a Berlin smartshop focused on ethnobotany and laboratory analytics. Every iboga batch is tested for identity, alkaloid profile, and purity; COAs can be viewed; origin and processing are documented. Sales are made exclusively to customers of legal age, without healing claims, as an ethnobotanical collector's item. Related content Iboga guide: tradition, pharmacology, application Legal status of iboga in Germany and internationally Iboga microdosing: fundamentals and context Ready to order iboga in verified quality? In the [amama iboga shop](/collections/iboga) you will find carefully curated iboga products — TA root bark, powder, capsules, and extracts — with botanical verification, complete laboratory analytics, and transparent origin. Shipping from Berlin, discreet packaging, age verification, buyer protection. [To the iboga collection →](/collections/iboga) This article serves informational and consumer-protection purposes. It contains no dosage recommendations for human consumption. Iboga products are offered as botanical samples or ethnobotanical collector's items. Sale exclusively to persons aged 18 and over. → Ibogaine Compound Profile — chemistry, pharmacology & references
Learn moreIboga vs. Psilocybin: Differences, Similarities and Areas of Application
This article is part of our [Iboga Guide](https://amama.space/blogs/plants/iboga-guide). TL;DR — Iboga and Psilocybin at a Glance > Iboga (Tabernanthe iboga) and psilocybin mushrooms are two of the most intensively researched plant-based entheogens of our time. They act on entirely different receptor systems, have different traditions and different clinical application profiles. Both are available in Germany in their natural, botanical form — with different legal nuances. > Mechanism of action: Ibogaine acts multi-receptorally (SERT, NMDA, κ-opioid, σ-2); psilocybin primarily as a 5-HT2A agonist. Experience duration: Iboga 24–36+ hours; psilocybin 4–6 hours. Safety: Ibogaine requires cardiac screening (ECG); psilocybin has a minimal cardiac risk profile. Research focus: Iboga → opioid dependence, PTSD, TBI; psilocybin → depression, anxiety, addiction. Legal status DE: Both available in natural form — iboga fully legal, psilocybin mushrooms in a legal grey area. At a Glance: The Direct Comparison Criterion Iboga Psilocybin Botanical source Tabernanthe iboga Psilocybe mushrooms Origin Central Africa (Gabon, Cameroon) Worldwide distribution Main alkaloid Ibogaine (tryptamine indole alkaloid) Psilocybin → psilocin Mechanism of action SERT, NMDA, κ-opioid, σ-2 5-HT2A agonism Experience duration 24–36+ hours 4–6 hours Traditional context Bwiti religion (initiation) Mesoamerican (Mazatec) Primary research indication Addiction treatment, PTSD, TBI Depression, anxiety, addiction Legal status DE ✅ Legal (plant & ibogaine) ✅ Mushrooms in natural form (grey area) Cardiac risk Yes — ECG required Minimal Intensity Very high Moderate to high Phenomenology Oneirogenic, introspective Visual, transpersonal Mechanism: Why They Work So Differently Perhaps the most important difference between iboga and psilocybin lies at the molecular level — and it explains why the two experiences differ so fundamentally. Psilocybin is a classical psychedelic in the strict sense. After oral ingestion, it is dephosphorylated to psilocin, which acts as a partial agonist at the serotonin 5-HT2A receptor. This receptor is considered a central switching point for the characteristic psychedelic phenomenology: visual intensification, ego dissolution, transpersonal experiences, synaesthetic perception. Studies suggest that 5-HT2A agonism dampens the so-called Default Mode Network (DMN) and temporarily rewires neural networks. Ibogaine, by contrast, is not a classical psychedelic. It binds to an unusually broad range of receptors: it inhibits the serotonin transporter (SERT), antagonises NMDA receptors (similar to ketamine), acts as a κ-opioid receptor agonist, and binds to σ-2 receptors. The active metabolite noribogaine has a longer half-life and contributes to the delayed, days-long lingering effect. Indole alkaloid · Tabernanthe iboga Ibogaine (1R,15R,17S,18S)-17-ethyl-7-methoxy-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene Molecular formula: C20H26N2O Molecular weight: 310.4 g/mol CAS: 83-74-9 Compound profile: Ibogaine → Indole alkaloid · Tabernanthe iboga Ibogaine (1R,15R,17S,18S)-17-ethyl-7-methoxy-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene Molecular formula: C20H26N2O Molecular weight: 310.4 g/mol CAS: 83-74-9 Read more about Ibogaine → This multi-receptoral activity leads to an experience that researchers often describe not as "psychedelic" in the classical sense, but as oneirogenic — dreamlike, introspective, film-like, with biographical memory sequences. Users report fewer classical visual hallucinations and more of a "life review" phenomenon. What both substances have in common: in preclinical studies, both ibogaine and psilocybin have been shown to promote neuroplasticity (BDNF expression, synaptic reorganisation) — albeit through different molecular pathways. The "reset" hypothesis (Alper 2012) posits that ibogaine specifically interrupts addiction-related neural pathways. Areas of Application Compared Both substances show promise in clinical studies — but for different indications. Where Iboga Is in the Research Spotlight Opioid dependence: Ibogaine is known for its ability to drastically reduce withdrawal symptoms in a single session. Treatment centres in Mexico, the Netherlands and Portugal use this clinically. Complex trauma & TBI: The Stanford study (Cherian et al., Nature Medicine 2023) examined 30 US military veterans with traumatic brain injury. The combination of ibogaine + magnesium showed significant improvements in PTSD, depression and anxiety. Severe addiction disorders: Methamphetamine, cocaine, alcohol — especially where classical approaches have repeatedly failed. Where Psilocybin Is in the Research Spotlight Treatment-resistant depression: COMPASS Pathways and other Phase 3 studies show significant effects after a single session. End-of-life anxiety: Johns Hopkins and NYU documented clear, long-lasting reductions in existential anxiety in cancer patients. Smoking cessation: Matthew Johnson et al. (Johns Hopkins) showed high abstinence rates after 6 months. Obsessive-compulsive disorder (OCD): Early studies suggest potential. Overlapping Indications PTSD Alcohol dependence Major depression The choice between iboga and psilocybin is therefore strongly context-dependent: the specific indication, physical condition, availability of medical infrastructure, and the individual's readiness for a multi-day versus multi-hour experience. From the archive Tabernanthe iboga — botanical specimen · Ji-Elle · 2018-05-24 Tabernanthe iboga plant at the Meise Botanic Garden, Belgium. Jardin botanique de Meise · CC BY-SA 3.0 Experience Duration: A Decisive Factor The difference in duration is not trivial — it determines protocol, setting and suitability. Iboga experience: 24–36+ hours A Bwiti initiation or a clinical ibogaine session extends over at least one day and one night. The phase of intense visions often lasts 8–12 hours, followed by an "introspection" or "grey-day" phase of another 12–24 hours. Physically, the experience is demanding: ataxia (inability to move), nausea and light sensitivity are typical. Sleep can be disturbed for several days. Psilocybin experience: 4–6 hours A classical psilocybin session has an onset phase of about 30–60 minutes, a peak of 2–3 hours and a come-down phase. Sleep is usually possible on the same night. The experience is intense but manageable in time. This difference explains why clinical psilocybin protocols often work in a single-day format, whereas ibogaine treatments require multi-day inpatient settings with overnight stays and medical monitoring. Safety Profile Here the arguably most important practical difference becomes apparent. Ibogaine: Cardiac Monitoring Mandatory Ibogaine prolongs the QT interval in the heart and can, in rare cases, lead to dangerous arrhythmias. According to data from the Global Ibogaine Therapy Alliance (GITA, 2015), approximately 1 in 300 cases without cardiac screening may be potentially life-threatening. Responsible use requires: ECG before the session Electrolyte check (potassium, magnesium) Liver values Exclusion of pre-existing cardiac conditions Medically supervised setting Clarification of all drug interactions (especially SSRIs, MAO inhibitors, opioids, QT-prolonging medications) Psilocybin: Minimal Cardiac Risk Psilocybin has a remarkably favourable physiological safety profile. It is neither nephro- nor hepatotoxic, causes no cardiac conduction disturbances and no physical dependence. The risks are almost exclusively psychological in nature: challenging experiences ("bad trips"), risk for those predisposed to psychosis, HPPD (Hallucinogen Persisting Perception Disorder) in isolated cases. In Common: Set & Setting Both substances require careful preparation, a trusting environment and competent guidance. For iboga this is non-negotiable for medical reasons; for psilocybin, for psychological ones. Anecdotal reports and initial long-term observations suggest that the longer and more intense iboga experience may enable deeper and more lasting transformations in suitable candidates — a price paid with higher physical risk and considerably more elaborate medical infrastructure. Legal Status: What Is Allowed Where? Both substances are in a legally interesting position in Germany — with important differences. Iboga & Ibogaine in Germany: Fully Legal Neither Tabernanthe iboga (the plant, root bark, seeds) nor ibogaine (the isolated alkaloid) are listed in the Narcotics Act (BtMG, annexes I–III) or in the New Psychoactive Substances Act (NpSG) (as of April 2026). This means: possession, purchase and sale as an ethnobotanical collector's item are legal. Ibogaine is not approved as a medicinal product in Germany — it is not sold as a food or medicine, but as a traditional botanical product. More on this: Iboga Legal Status Germany. Psilocybin Mushrooms: More Nuanced The legal situation for Psilocybe mushrooms is more differentiated: Isolated psilocybin and dried fruiting bodies are listed in BtMG Annex I — prohibited. Fresh, naturally growing mushrooms have not been unambiguously assessed as subject to the BtMG in some rulings — a grey area that is interpreted differently depending on the federal state and individual case. Spores and cultures are generally legal, as they themselves contain no psilocybin. European Overview Country Iboga/Ibogaine Psilocybin mushrooms Germany ✅ Legal ⚠️ Grey area (fresh), prohibited (dried) Netherlands ✅ Legal (treatment centres) ✅ Truffles legal Portugal ✅ Legal (retreats) Decriminalised Switzerland ❌ Prohibited ❌ Prohibited France ❌ Prohibited ❌ Prohibited Belgium ❌ Prohibited ❌ Prohibited German-speaking individuals seeking a guided ibogaine or psilocybin experience typically travel to the Netherlands or Portugal. Conclusion: Which Substance for Whom? Neither iboga nor psilocybin is "better" — both substances have distinct profiles and are suited to different situations. Iboga may be relevant in a research context for: Severe, long-term addiction (especially opioids) Complex trauma-related disorders, TBI Situations where classical therapy has repeatedly failed Willingness to undergo a multi-day, physically demanding setting with medical monitoring Psilocybin may be relevant for: Treatment-resistant depression Existential anxiety, end-of-life contexts Smoking cessation, alcohol problems Desire for a shorter, time-limited experience Pre-existing cardiac conditions that rule out ibogaine The choice is a clinical, personal and contextual one. Both substances deserve respect — not hype. Neither is a "miracle cure", and both require serious preparation and competent guidance. An often overlooked point: iboga is the legally clearer option in Germany. While psilocybin mushrooms exist in a fragile grey area, Tabernanthe iboga is unambiguously legally available as an ethnobotanical product — which explains why interest among German collectors and researchers in this plant has risen sharply in recent years. Our selection Iboga Tabernanthe iboga is a perennial rainforest shrub native to Central Africa, particularly Gabon and Cameroon, where it has been used for centuries in Bwiti initiation ceremonies. The root bark… → Shop the collection Back to the Overview Back to the Iboga Guide | Iboga Effects | Iboga Legal Status | Iboga Therapy Last updated: April 2026. This content is for informational purposes only and does not constitute medical advice. → Ibogaine Compound Profile — chemistry, pharmacology & references
Learn more
Ibogaine Therapy in Europe: Clinics, Research Status and Safety
This spoke is part of our Iboga Guide. TL;DR — Ibogaine Therapy in Europe Indole alkaloid · Tabernanthe iboga Ibogaine (1R,15R,17S,18S)-17-ethyl-7-methoxy-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene Molecular formula: C20H26N2O Molecular weight: 310.4 g/mol CAS: 83-74-9 Read more about Ibogaine → > Ibogaine, the main alkaloid of the Central African plant Tabernanthe iboga, has been researched since the 1980s in medically supervised settings for the treatment of opioid dependence, alcoholism, PTSD and treatment-resistant depression. In Germany, ibogaine is not approved as a medicine, so German-speaking patients typically travel to legal treatment centers in Portugal, Spain or the Netherlands. Due to serious cardiac risks (QT prolongation), a complete medical screening before any use is indispensable. > Main indications in research: opioid detox, alcohol dependence, PTSD, treatment-resistant depression, TBI rehabilitation Mechanism of action: "neuronal reset" via GDNF normalization, serotonergic modulation, memory reconsolidation European options: Tabula Rasa Retreat (Portugal), Madera Sagrada (Spain), several Amsterdam clinics (Netherlands) Mandatory screening: ECG, liver values, medication history, psychiatric evaluation Risk without screening: approx. 1 in 300 cases potentially life-threatening (GITA data) What is ibogaine used for therapeutically? Clinical research on ibogaine focuses on indications where conventional therapies often reach their limits — particularly chronic addictive disorders and trauma-related conditions. Characteristically, even a single supervised session has shown long-lasting effects in several observational studies, whereas many standard therapies rely on permanent medication. Indole alkaloid · Tabernanthe iboga Ibogaine (1R,15R,17S,18S)-17-ethyl-7-methoxy-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene Molecular formula: C20H26N2O Molecular weight: 310.4 g/mol CAS: 83-74-9 Compound profile: Ibogaine → Indication Research Status Evidence Level Opioid dependence (withdrawal interruption) Mash et al. (2018, St. Kitts cohort, n=191); Noller et al. (2018, New Zealand cohort, 12-month follow-up) Observational studies, no RCT Alcohol dependence Preclinical (Carnicella et al. 2010); smaller case series Early PTSD / trauma (veterans) Cherian et al. (2023, Stanford, Nature Medicine, n=30) — ibogaine + magnesium, significant reduction of PTSD, depression, anxiety, disability Open-label, pilot study Treatment-resistant depression Alper et al. (2012) — review; MAPS-funded follow-up studies ongoing Early TBI (traumatic brain injury) Stanford 2023 — veterans with traumatic brain injury Early, exploratory The Stanford study (Cherian et al. 2023) is so far the methodologically most robust data point: 30 US veterans with combined diagnoses (PTSD, depression, TBI) received ibogaine together with intravenous magnesium at a Mexican clinic. The effect sizes after one month were unusually large — however, this is an uncontrolled observation, not a randomized trial. A follow-up study with a control group is in preparation. The neurobiological reset: how ibogaine affects addiction pathways The so-called "neuronal reset" hypothesis (Alper 2012) describes why a single ibogaine session can produce effects that repeated doses of other substances fail to achieve. Several mechanisms presumably interact: GDNF restoration. Carnicella et al. (2010) showed in animal models that ibogaine increases the concentration of glial cell line-derived neurotrophic factor (GDNF) in the ventral tegmental area (VTA). GDNF stabilizes dopaminergic neurons whose signaling becomes dysregulated by chronic substance use. This may explain why craving for opioids and alcohol measurably decreases after a single session. Serotonergic normalization. Ibogaine acts as a serotonin reuptake inhibitor and modulates several 5-HT receptors. Combined with its NMDA-antagonistic action, this yields a profile with parallels to ketamine — but with a significantly longer duration of action (12–36+ hours). Memory reconsolidation via sigma-2 receptors. Ibogaine shows pronounced affinity for the sigma-2 receptor, which is involved in memory processes and emotional processing. Studies suggest that during the active window, traumatic and addiction-associated memories may be re-"stored" in a plastic state — a process that many treated individuals subjectively describe as an intense life review. Noribogaine as long-term metabolite. The liver metabolite noribogaine is pharmacologically active, has a half-life of several days, and is considered co-responsible for the sustained anti-craving window following the acute session. From the archive Tabernanthe iboga — botanical specimen · Ji-Elle · 2018-05-24Tabernanthe iboga plant at the Meise Botanic Garden, Belgium.Jardin botanique de Meise · CC BY-SA 3.0 Treatment options in Europe (for German-speaking patients) Since ibogaine is not approved as a medicine in Germany (but is legally possessable — neither Tabernanthe iboga nor ibogaine are listed in the BtMG or NpSG), therapeutic use takes place almost exclusively abroad within Europe. The following centers are considered established and work with medical personnel and cardiac screening: Center Country Specialization Note Tabula Rasa Retreat Portugal (Sintra) Addiction, PTSD, depression Medically supervised, mandatory cardiac screening, structured integration Madera Sagrada Spain (Órgiva) Addiction, trauma Ceremonial + therapeutic programs, Bwiti influences Amsterdam clinics Netherlands Opioid detox, depression Ibogaine legal, several centers, often physician-led Iboga Life / ex-Sanandao network Portugal / Netherlands Addiction International orientation Belgium, France, Switzerland, the United Kingdom, Ireland, Sweden and Norway have banned ibogaine — treatment is not legally possible there. What patients can expect: a typical process 1. Intake and pre-screening (weeks in advance). Medical history, medication list, psychiatric assessment. Many centers require a current cardiology report including 12-lead ECG, liver values, kidney function and a pregnancy test. QT-prolonging medications (certain antidepressants, antibiotics, antipsychotics) are absolute exclusion criteria if they cannot be discontinued in time. 2. Medication tapering. SSRIs, SNRIs, MAO inhibitors and opioid agonists (methadone, buprenorphine) must be discontinued before the session or switched to short-acting substitutes. This is done under medical supervision, often over 2–6 weeks. 3. Arrival and on-site check (1–2 days). Repeat ECG, blood pressure baseline, electrolyte check (especially potassium and magnesium). Psychological preliminary interview, goal setting. 4. Treatment day. The session takes place in a quiet, darkened room with medical personnel present. Continuous ECG monitoring over 12–24 hours is standard. The acute effect lasts 8–12 hours, subtle after-effects 24–36 hours. 5. Follow-up observation (at least 24h). Transition into a rest phase. No being alone during the first 48 hours. 6. Integration. Reputable centers offer several integration sessions — on-site and/or remotely in the weeks after. The length of stay is typically 5–7 days minimum, longer in complex cases. Safety protocol: what every reputable clinic must ensure The Global Ibogaine Therapy Alliance (GITA) published guidelines in 2015 that today represent the international de facto standard. A responsible clinic meets at least the following criteria: Complete cardiac assessment: 12-lead ECG with QTc measurement, echocardiogram if structural heart disease is suspected, electrolyte status Medication history and tapering under medical supervision Exclusion criteria: current SSRI/SNRI use, opioid agonists without switching, severe liver/kidney disease, pregnancy, active psychosis, long QT syndrome, severe coronary heart disease Psychological evaluation before treatment Presence of a physician or emergency paramedic throughout the entire acute phase Continuous cardiac monitoring at least during the first 12 hours Emergency equipment (defibrillator, IV magnesium, advanced resuscitation medication) Structured integration after the session From the known fatalities of recent decades (Alper et al. 2012, retrospective analysis), it can be inferred: approximately 1 in 300 cases without adequate cardiac screening can potentially be life-threatening. The majority of these events occurred in underground settings with unknown health status, mixed consumption or QT-prolonging medications that had not been discontinued. Ibogaine therapy should take place exclusively in medically supervised settings with complete cardiac screening. Underground sessions, weekend "retreats" without a physician and self-administration are not serious options — regardless of the substance's legal status. Excursus: Bwiti ceremonies vs. clinical application Traditional Bwiti initiation in Gabon and Cameroon and clinical ibogaine treatment are historically related but structurally different practices. One is not a substitute for the other. Aspect Bwiti ceremony Clinical ibogaine therapy Substance Crushed root bark, full alkaloid complex Isolated ibogaine HCl (pharmaceutical purity) Setting Community house, drums, singing, Nganga (ceremony leader) Clinic room, medical monitoring, therapists Objective Spiritual initiation, ancestor contact, rite of passage Symptom reduction, craving interruption, trauma processing Framework interpretation Religious-cosmological Clinical-psychological Duration Often 2–3 days 1 day acute + integration Risk profile Depends on participants' health; traditionally without ECG Medically secured Both contexts are legitimate within their respective traditions. Western patients seeking a therapeutic intervention, however, should clearly distinguish between ceremonial and clinical ibogaine use — and honestly assess which framework suits their concern and state of health. Some European centers (such as Madera Sagrada) deliberately work with hybrid formats, combining ceremonial elements with medical safeguards. Outlook: Will ibogaine come to Germany? The regulatory landscape has changed significantly between 2023 and 2026. Several developments suggest that ibogaine will come into greater focus of European regulatory authorities in the coming years: Stanford 2023 delivered the first high-quality pilot study in a Western academic context Texas approved 100 million US dollars for ibogaine research in 2025 — the largest single psychedelic research funding in US history Trump's Executive Order of April 18, 2026 mandates the FDA with an accelerated review procedure for ibogaine MAPS and other organizations are advancing clinical Phase II studies For German approval, the realistic path would be: EMA-compliant Phase II and Phase III studies (usually 3–6 years) BfArM review following successful EMA evaluation Pilot programs in university clinics, possibly initially within the framework of compassionate use regulations (§ 41 AMG) The Netherlands and Portugal could serve as EU-internal model states, since clinical infrastructure and experience already exist there A realistic forecast: 5–10 years until a possible regular approval of ibogaine as a medicine in Germany — provided that the ongoing Phase II studies deliver positive safety and efficacy data. Until then, the legal situation remains as it is: ibogaine is legally possessable in Germany, but not an approved medicine, and therapeutic use takes place abroad within Europe. Back to the overview Back to the Iboga Guide | Iboga Effects | Iboga Legal Status 2026 | Iboga vs. Psilocybin Collection Iboga Tabernanthe iboga is a perennial rainforest shrub native to Central Africa, particularly Gabon and Cameroon, where it has been used for centuries in Bwiti initiation ceremoni… → Shop the collection Last updated: April 2026. This content is for informational purposes only and does not constitute medical advice. Not a medical product. For medical questions, please consult a physician. → Ibogaine Compound Profile — chemistry, pharmacology & references
Learn moreIboga & Legal Status 2026: What Trump's Executive Order Means for Germany
This post is part of our [Iboga Guide](https://amama.space/blogs/plants/iboga-guide). TL;DR — Iboga is legal in Germany, and the broader political climate is shifting dramatically in 2026. On 18 April 2026, US President Donald Trump signed an Executive Order accelerating the FDA review of psychedelics — explicitly including ibogaine. For Germany, this means no immediate legal change, but massive research and evidence pressure on the EMA and BfArM. Here is the current context at a glance. ✅ Germany: Tabernanthe iboga and ibogaine are listed neither in the BtMG nor in the NpSG — legal as a botanical. USA (April 2026): Trump EO accelerates FDA review of ibogaine; USD 50 million via ARPA-H; Joe Rogan was present at the signing. Treatment access: The Netherlands and Portugal offer medically supervised programs — German patients increasingly travel there. ⚠️ Safety: Ibogaine may prolong the QT interval. Potentially life-threatening without cardiological screening (approximately 1 in 300 cases in older case series). amama position: We sell iboga root bark as a traditional ethnobotanical — not a medicine, not a food, not a therapy referral. Current Developments (Newsfeed) 18 April 2026 — Trump signs Executive Order on psychedelics (incl. ibogaine) > US President Donald Trump signed an Executive Order accelerating FDA review of psychedelics — including ibogaine, psilocybin, LSD, MDMA and ketamine — for psychiatric indications. The order allocates USD 50 million via the Advanced Research Projects for Health (ARPA-H) program and opens a path to approval under the "Right to Try Act". Joe Rogan was present at the White House signing — he had previously alerted Trump to ibogaine via text message. Trump's reply, according to Fortune Magazine: "Sounds great. Want FDA approval? Let's do it." Ibogaine remains Schedule I for now — but the EO creates research and access corridors. > Source: CNBC, 18 April 2026 | White House Fact Sheet 1 April 2026 — Joe Rogan Experience #2477: Rick Perry & Bryan Hubbard on the Texas Ibogaine Initiative > Former Texas Governor Rick Perry and activist W. Bryan Hubbard discussed the Texas Ibogaine Initiative on JRE #2477 — the largest state-level psychedelics research program in US history. Texas had already committed USD 100 million to ibogaine research in 2025. Perry: "Ibogaine has the potential to solve our veterans crisis." Rogan: "This is one of the most important shows I've ever done." The episode was streamed over 10 million times within 48 hours and brought ibogaine into mainstream discourse. 2025 — Stanford study: Ibogaine in war veterans with PTSD and traumatic brain injury > A study by Stanford University (Cherian et al., Nature Medicine, 2023, extended with follow-up data in 2025) examined 30 US military veterans with PTSD, depression and traumatic brain injury. A single ibogaine session (with magnesium supplementation to mitigate cardiac risk) led to significant improvement of PTSD symptoms, which persisted for months after treatment. The study is the most robust clinical signal to date for ibogaine's psychiatric potential in severe trauma cases. 2025 — Texas: USD 100 million for ibogaine — largest US psychedelics program > Under Governor Greg Abbott, Texas became the first US state to allocate USD 100 million in public funds for ibogaine research — more than any other state-level psychedelics initiative worldwide. The focus: veterans with PTSD and opioid dependence. In parallel, 181 Texas legislators backed an initiative for ibogaine decriminalization. November 2025 — Germany: Ibogaine still NOT in BtMG or NpSG > The German Federal Ministry of Health confirmed in response to a parliamentary inquiry that neither Tabernanthe iboga nor ibogaine is listed in the annexes of the Narcotics Act (BtMG) or the New Psychoactive Substances Act (NpSG). No applications for inclusion are pending. Iboga remains legally tradeable in Germany as a traditional plant — though not as a medicine or food. Legal Status in Germany: What Is Permitted? The German legal situation regarding iboga is clear, if surprising to many: Neither the plant Tabernanthe iboga nor its main alkaloid ibogaine is prohibited in Germany. Both are listed neither in Annexes I, II or III of the Narcotics Act (BtMG) nor in the New Psychoactive Substances Act (NpSG). This sets iboga apart from almost all other classical psychedelics — psilocybin, LSD, DMT and mescaline are all BtMG-listed in Germany. What does this mean in practice? Possession, purchase and sale of iboga root bark as a botanical product are legal. Not approved as a medicinal product: Physicians may not prescribe ibogaine in Germany, as it has no approval under the Medicines Act (AMG). Not approved as a food or dietary supplement: It may not be advertised with health claims (Health Claims Regulation, Novel Food Regulation). Isolated ibogaine: If placed on the market as a medicinal product (e.g. with healing claims), the AMG applies — then sale without approval would not be permissible. As a reference substance for research or as a collector's item, the situation is less clear-cut. amama sells iboga root bark exclusively as a traditional ethnobotanical product — without medicinal or dietary intended purpose. Legal Overview at a Glance Status Germany Possession ✅ Legal Purchase ✅ Legal Sale as botanical ✅ Legal As a medicine ❌ Not approved As a food ❌ Not approved Medical therapy ❌ No approval This constellation — legal botanical, but no medical approval — is typical for many ethnobotanical plants (cf. kratom, kanna, blue lotus). It opens up a legal collector and research space, while therapeutic applications are outsourced abroad. European Legal Landscape Overview Europe is divided on iboga. While some countries traditionally take a liberal approach to ethnobotanical substances, others have explicitly banned iboga — often following isolated deaths at unregulated retreats. Country Status Note Germany ✅ Legal Not in BtMG/NpSG Netherlands ✅ Legal Treatment centres active Portugal ✅ Legal Retreat clinics (Tabula Rasa Retreat, Sintra) Spain ✅ Legal Madera Sagrada Retreat (Órgiva) Switzerland ❌ Banned Federal Narcotics Act Belgium ❌ Banned Safety concerns France ❌ Banned Since 2007 (stupéfiant list) Norway ❌ Banned Sweden ❌ Banned Ireland ❌ Banned United Kingdom ❌ Banned Psychoactive Substances Act 2016 Particularly relevant for German-speaking patients: Austria does not explicitly address ibogaine in its Narcotic Substances Act, though interpretation is inconsistent. In Switzerland, ibogaine has been listed in the Federal Narcotics Act for years and is therefore illegal. From the archive Iboga root bark pieces · Kim Gjerstad · 2011-11-22 Dried root bark pieces of Tabernanthe iboga — the primary traditional preparation used in Bwiti ceremony. Wikimedia Commons · CC BY-SA 4.0 What Does Trump's Executive Order Mean for Europe? The US Executive Order of 18 April 2026 formally changes nothing under European law. US orders have no extraterritorial effect on the EMA, BfArM or national legislators. The indirect impact, however, is considerable: 1. Accelerated clinical evidence. The EO unlocks USD 50 million in ARPA-H funding and fast-tracked FDA procedures. The resulting Phase II and Phase III studies automatically become part of the global evidence base that the European Medicines Agency (EMA) evaluates in its own approval processes. MAPS and related consortia have already signalled that they will include European study sites. 2. Precedent pressure on EU member states. If the FDA approves ibogaine for opioid dependence or PTSD, political pressure will build on European authorities not to withhold access indefinitely — especially if German veterans and addiction patient groups cite US data. 3. Research funding. US funding increases global academic capacity. German universities (including Charité and Heidelberg University) are already actively monitoring the psychedelics field; the Stanford data are increasingly cited in European reviews. 4. Netherlands and Portugal as observation zones. Both countries have liberal regulations and active treatment centres. They could — similar to MDMA-assisted therapy — serve as European pilot regions long before Germany takes formal steps. 5. Patient advocacy. In Germany, smaller groups (especially from the Bundeswehr and opioid-withdrawal communities) have organised to push for legal therapeutic access. US developments reinforce their arguments. What Could a German Approval Pathway Look Like? Medical approval in Germany would follow the standard Medicines Act (AMG) pathway: Preclinical and clinical studies to EMA standard (Phase I–III). Approval application to the Federal Institute for Drugs and Medical Devices (BfArM) or via the centralised EMA procedure. Risk management plan — particularly given the known QT prolongation, a rigorous cardiac screening protocol would be mandatory. G-BA assessment and reimbursement decision. Realistic time horizon: 2028–2030 at the earliest, even under favourable conditions. Until then, the German situation stands: plant legal, therapy not. Treatment in Europe: Where Do German-Speaking Patients Travel? The following information is provided for orientation only — amama does not offer or refer to treatments. German-speaking patients seeking medically supervised ibogaine treatment typically look to three destinations: Netherlands: Established treatment centres have been operating in the greater Amsterdam area for years, with medical staff, pre-screenings and ECG monitoring. Frequently used for opioid dependence. Portugal — Tabula Rasa Retreat (Sintra): Medically supervised program, mandatory cardiological screening, multi-day retreat format. Spain — Madera Sagrada (Órgiva, Andalusia): Smaller centre with a traditional/ceremonial orientation, likewise with medical screening. GITA Safety Standards (Non-Negotiable) The Global Ibogaine Therapy Alliance (GITA) published minimum standards in 2015 that are adhered to by reputable providers. These include: 12-lead ECG before the session, ruling out QT prolongation Cardiac history and, if necessary, echocardiography Electrolyte monitoring (potassium, magnesium) — magnesium supplementation is now standard Discontinuation of interacting medications (SSRIs, methadone, QT-prolonging substances) Continuous monitoring throughout the entire session (12–36+ hours) On-site medical emergency staff ⚠️ Safety notice: Ibogaine may prolong the QT interval and, in rare cases, trigger cardiac arrhythmias. Older case series report approximately 1 life-threatening event per 300 sessions without adequate screening. With full cardiological screening, magnesium supplementation and medical monitoring, this risk drops considerably. Anyone considering treatment should choose exclusively medically supervised settings — never informal or unscreened ceremonies. More on the therapeutic context in the spoke Iboga Therapy. amama's Position amama is a Berlin ethnobotanical smartshop. We sell iboga root bark as a traditional ethnobotanical product — without medicinal or dietary intended purpose, within the framework of German law. We do not offer ibogaine therapies, do not refer to retreats, and do not give dosage recommendations. We support evidence-based research and the right of adult, informed individuals to make their own decisions. We comply with the relevant German regulations (BtMG, NpSG, AMG, LFGB, Health Claims Regulation). For anyone engaging with iboga scientifically or culturally, we provide high-quality material of traceable origin — along with accompanying informational content. Collection Iboga Tabernanthe iboga is a perennial rainforest shrub native to Central Africa, particularly Gabon and Cameroon, where it has been used for centuries in Bwiti initiation ceremoni… → Shop the collection Our selection Iboga Tabernanthe iboga is a perennial rainforest shrub native to Central Africa, particularly Gabon and Cameroon, where it has been used for centuries in Bwiti initiation ceremonies. The root bark… → Shop the collection Further Topics Back to the Iboga Guide | Iboga Effects | Iboga Therapy | Iboga vs. Psilocybin Last updated: 19 April 2026. Legal information provided without warranty — consult a lawyer for individual legal questions. This content is for informational purposes only and does not constitute medical advice. → Ibogaine Compound Profile — chemistry, pharmacology & references
Learn more